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Introduction and Hypothesis 1 
1 Introduction and Hypothesis 
According to the International Diabetes Federation approximately 285 million people 
worldwide suffered from Diabetes mellitus in the year 2010. According to the “Austrian 
diabetes report” 600 000 diabetics in Austria were estimated in the same year. 
Approximately 95% of people suffering from diabetes have Diabetes mellitus Type 2 
(T2DM), which it is formally known as Non-insulin-diabetes mellitus. T2DM is now 
one of the most common diseases worldwide and its prevalence is expected to increase 
by 7.7 % in 2030. 
 
DMT2 is a heterogenous disorder characterized by impaired insulin secretion and 
insulin action that leads to hyperglycaemia. Elevated free fatty acids and oxidative 
stress exacerbate the metabolic abnormalities in diabetes and its long-term 
complications, and may be involved in the pathogenesis of this disease. Oxidative Stress 
may also lead to high levels of DNA damage, and it has also been linked to insulin 
resistance and beta cell dysfunction, which may cause increased damage to 
deoxyribonucleic acid (DNA). 
 
The hypothesis that a daily consumption of vegetables rich in antioxidants and vitamins 
in combination with a plant oil rich in polyunsaturated fatty acids (PUFAs) may have 
protective effects on oxidative DNA damage and the development of late complications  
in diabetics, provided the basis to perform the DIAPLANT study. The aim of this 
experimental study was to evaluate the influence of a daily intervention of 300 g 
vegetables and 25 ml plant oil for eight weeks on oxidative DNA damage in T2DM. 
This thesis is a part of the DIAPLANT study and investigated especially the effect of 
this intervention on subjects with non-insulin-dependent T2DM. 
 
The thesis was written together with Simone Pleifer. We performed the experimental 
part of this thesis study and the chapters “Literature survey” and “Material and 
Methods” were written together and are identical. 
 
 
  
2  Literature survey 
2 Literature survey 
2.1 Diabetes mellitus 
2.1.1 Definition and Classification 
Diabetes mellitus comprises a group of metabolic disorders and is characterized by high 
blood sugar levels, which are a consequence of impaired insulin secretion and insulin 
function that lead to hyperglycaemia. Hyperglycaemia is correlated with long-term 
damage, dysfunction and failure of different organs, especially eyes, kidneys, nerves, 
heart and blood vessels. Specific pathogenic processes are the consequence in diabetes. 
That comprehends from autoimmune destruction of the ß-cells in the pancreas with 
consequent insulin deficiency to abnormalities that result in resistance to insulin. In case 
there is not enough insulin, or it is not working properly, the blood glucose rises and 
leads to abnormalities in carbohydrate-, fat-, and protein metabolism [ADA, 2010a]. An 
etiologic classification of diabetes is shown in Tab. 1. 
The status of pre diabetes occurs when abnormalities of glucose metabolism exist but 
the diagnostic criteria for diabetes are not met. Tab. 2 shows the diagnostic criteria. 
These conditions of pre diabetes can be unchanged for many years. If the blood glucose 
level is abnormal, impaired fasting glucose (IFG) is diagnosed. Determination following 
the oral glucose tolerance test (measure of two hours after 75 g oral glucose load) is 
defined as impaired glucose tolerance (IGT). It occurs when beta cell function is 
inadequately low for a specific degree of insulin sensitivity [SMUSHKIN and VELLA, 
2010]. 
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Tab. 1: Etiologic classification of diabetes mellitus according to ADA, 2010 
I. Type 1 diabetes: ß-cell destruction, usually leading to absolute insulin 
deficiency  
a. Immune mediated  
b. Idiopathic 
II. Type 2 diabetes: ranging from predominantly insulin resistance with relative 
insulin deficiency to predominantly an  insulin secretory  defect with insulin 
resistance 
III. Other specific types of diabetes  
a. Genetic defects of ß-cell function 
b. Genetic defects in insulin action 
c. Diseases of the exocrine pancreas 
d. Endocrinopathies 
e. Drug or chemical induced 
f. Infections 
g. Uncommon forms of immune-mediated diabetes 
h. Other genetic syndromes sometimes associated with diabetes 
IV. Gestational diabetes mellitus 
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Tab. 2: Diabetes diagnostic criteria, according to ADA, 2010 
Diabetes 
Fasting plasma glucose   ≥ 7.0 mmol/l (126 mg/dl)  
or 
2–h post glucose load   ≥ 11.1 mmol/l (200 mg/dl) 
Haemoglobin A1c (HbA1c) ≥ 6.5% 
IFG and/or IGT (is referred to as having pre diabetes) 
Fasting plasma glucose        5.6 mmol/l to 6.9 mmol/l (100 mg/dl to 125 mg/dl) [IFG] 
and/or 
2-h post glucose load             7.8 mmol/l to 11.0 mmol/l (140 mg/dl to 199 mg/dl) [IGT] 
and 
HbA1c                                    5.7 – 6.4% 
2.1.2 Diabetes Mellitus Type 2 (T2DM) 
T2DM accounts for approximately 90-95% of all diabetes cases worldwide. It is 
formally known as non-insulin-dependent diabetes mellitus (NIDDM), or non-immune-
mediated diabetes. This form of diabetes results from an interaction between genetic 
and environmental factors and appears usually in people over the age of forty. T2DM 
occurs in individuals who have insulin resistance and relative insulin deficiency. It is 
often associated with obesity, which itself can induce some degree of insulin resistance 
and lead to elevated blood glucose levels. Nowadays T2DM becomes more and more 
common in children, adolescents and young people of all ethnicities and it is associated 
with a higher genetic predisposition than diabetes mellitus type 1 (T1DM), which is 
known as insulin-dependent diabetes mellitus (IDDM) [ADA, 2010a]. 
2.1.2.1 Pathogenesis 
In a healthy human organism the blood glucose level is kept in a tightly controlled range 
< 5.6 mmol/l (100 mg/dl) [ADA, 2010a].  
The normal glucose tolerance is mainly regulated by the interplay of insulin action and 
insulin secretion. It is needed to stimulate glucose uptake from the blood into various 
tissues. Depending on the blood glucose concentration in the blood, insulin is secreted 
by the beta cells of the Langerhans` islets in the pancreas. Increased insulin levels 
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inhibit glucagon release from alpha cells in the pancreas. It promotes the conversion of 
glucose into glycogen and inhibits lipolysis in adipose tissue.  
Multiple mechanisms lead to T2DM. Beside the genetic predisposition and 
environmental aspects also other factors, such as impaired glucose homeostasis, are 
discussed. Defects in glucose homeostasis decrease insulin resistance and have negative 
impact on beta cell function. Insulin resistance appears early in this disease, usually 
when glucose values are still within the normal glucose tolerance range. As glucose 
tolerance moves from regular to minimally impaired, the insulin secretion that occurs 
within the first thirty minutes after meal consumption becomes weak. The dysfunction 
in insulin secretion arises long before the onset of T2DM. It is not decrease of insulin 
resistance that causes blood glucose values to induce IGT, but it is the dysfunction of 
beta cells [LEAHY, 2005]. 
In addition to increased insulin resistance a steady decline of beta cells follows, the 
body cannot transfer glucose to the cells any longer which results in diabetes. Beta cell 
dysfunction is a critical stage in the pathogenesis of T2DM [STUMVOLL et al., 2005]. 
High triglycerides and free fatty acids, which are typical for T2DM, also contribute to 
the pathogenesis of the disease. Experimental studies discussed a causative event in the 
transition from normal to abnormal glucose tolerance and propose an interaction of 
glucose toxicity and lipotoxicity, termed glucolipotoxicity [LEAHY, 2005]. 
Glucose toxicity leads to an irreversible damage of beta cells caused by chronic 
exposure to hyperglycaemia. Robertson et al. hypothesised in their study that decreased 
insulin action and secretion are caused by reduced insulin gene expression. Also chronic 
oxidative stress may be an important mechanism for glucose toxicity [ROBERTSON et 
al., 2003]. 
T2DM is treated with healthy diet, physical activity and a combination of oral 
hyperglycaemic drug application with lipid-lowering, antihypertensive and antiplatelet 
therapy. If stable metabolic control is not achievable exogenous insulin is required 
[ADA, 2010a]. 
2.1.2.2 Complications 
Diabetes is one of the leading causes of death and affects many major organ systems 
where the most significant, and often fatal, diabetes complications occur. The 
mechanisms involve the direct toxic effects of high glucose levels, along with the 
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impact of elevated blood pressure, abnormal lipid levels and both functional and 
structural abnormalities of blood vessels. In addition to acute complications like 
severely elevated blood sugar levels and abnormally low blood sugar levels, chronic 
complications develop gradually. Long-term complications are related to blood vessel 
diseases and are generally classified into small vessel disease and large vessel disease 
[IDF, 2010a]. 
The management of T2DM should be further optimized to reduce the incidence of 
complications. Type 2 diabetics have in comparison to healthy individuals, shorter life 
expectancy and reduced quality of life due to late diabetes complications [RAKOVAC 
et al., 2009]. 
2.1.2.2.1 Microvascular complications 
Microvascular complications involve the eyes, kidneys and nerves. Diabetes can harm 
vision and initiate diabetic retinopathy. Both macular oedema, caused by a fluid 
accumulation behind the retina of the eye and impair small blood vessels in the back of 
the eye, in consequence of the leakage of protein and blood in the retina, induce 
blindness. In addition to blindness, diabetes also increases the risk of cataracts and 
glaucoma [ADA, 2010b]. 
Diabetic nephropathy includes kidney damage. Impaired small blood vessels in the 
kidneys cause the leakage of protein into urine. The accumulation of toxic waste 
products in the blood leads to dialysis or organ transplantation. 
When blood glucose and blood pressure are not controlled properly diabetes can impair 
nerves. The overload of sugar can injure the capillary walls that nourish the nerves, 
especially in the legs. Nerve damage in these areas is called peripheral neuropathy or 
diabetic neuropathy. Tingling, numbness, burning or pain lead to a loss of sense of 
feeling in the affected limbs. Minor foot injuries can produce serious infections, ulcers, 
gangrene and may require amputation of infected parts. Nerves of the digestive tract can 
also be affected and initiate nausea, vomiting, diarrhoea or constipation and erectile 
dysfunction. Beside these major microvascular diseases diabetes may lead to a higher 
susceptibility to skin and oral mucosa problems. Itching, bacterial-, fungal- and gum 
infections may occur which might also lead to hearing impairment in cause of diabetes 
mellitus [IDF, 2010a]. 
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2.1.2.2.2 Macrovascular complications 
Diabetes leads to accelerate hardening of arteries of the larger blood vessels and 
initiates dramatically an increased risk in coronary heart diseases. Cardiovascular 
disease (CVD) is the major cause of death in diabetes [ADA, 2010b]. According to the 
“American Heart Association” about 65 % of diabetics die of some type of heart or 
blood vessel disease [AHA, 2011]. 
To reduce macrovascular complications it is of primary importance to control 
hypertension, hyperlipidaemia, insulin resistance and obesity [JÖNSSON, 2002]. In 
addition diabetes may lead to lower bone mineral density and increased risk of 
osteoporosis. The poorer blood sugar levels are controlled, the greater the risk of 
Alzheimer´s disease and vascular dementia appears to be. Cardiovascular problems 
caused by diabetes might lead to dementia by blocking blood flow to the brain or cause 
stroke. Too much insulin in the blood leads to brain damaging inflammations, while 
lack of insulin in the brain deprives brain cells of glucose [ADA, 2010b]. 
2.1.3 Prevalence of late diabetic complications in Austria 
The prevalence of long-term complications in Austria is high and comparable with other 
European countries. In the Austrian study “Health status of type 2 diabetic patients - 
perspective of a quality improvement initiative” data were collected from 1997 to 2007 
in order to estimate the incidence of late complications of type 2 diabetic patients. Data 
from 23 641 subjects were analysed. Each fifth Austrian diabetic patient was affected at 
least by one kind of complication like amputation, heart attack, stroke, blindness or 
dialysis [RAKOVAC et al., 2009]. 
2.1.4 Epidemiology 
2.1.4.1 Worldwide 
Diabetes is one of the most prevalent non-communicable diseases globally. In 
accordance with the “Diabetes Atlas” of the International Diabetes Federation (IDF) it is 
the fourth or fifth leading cause of death in most high-income countries [IDF, 2010b]. 
Studies from 91 countries were used to describe the world prevalence of diabetes. In the 
year 2010 they estimated 285 million people living with diabetes. The study-population 
contains adults aged between 20-79 years. The majority of diabetics in industrialized 
countries are aged over 60 years. Affected people are younger in developing countries. 
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The uppermost regional prevalence was counted for North America, followed by the 
Eastern Mediterranean, Middle-East and South Asia [SHAW et al., 2010]. 
The incidence of T2DM is increasing worldwide, often in countries that cannot achieve 
the resulting medical and financial burdens [LEAHY, 2005]. 
The prevalence will increase to 7.7% or 439 million diabetic people in the year 2030. 
The African region is expected to have the largest proportional growing in adult 
diabetes and North America will continue to have the world´s highest prevalence. Over 
the next 20 years population growth, ageing of residence group and urbanization 
associated with lifestyle change is predicted to lead to a 54% rise of the total number of 
diabetics worldwide [SHAW et al., 2010].  
2.1.4.2 Austria 
About 600 000 Austrians suffered from diabetes mellitus in the year 2010 and only 
420.000 people are official diagnosed with this disease. The estimated number of 
unreported cases is about 30%, similar to other developed countries. It is recognized 
that in Austria 20% of all people at risk already have clinical late complications of 
diabetes by their first diagnose of T2DM. These complications could be prevented if the 
diagnosis occurs in time. The process of an early diagnosis, the right treatment and the 
prevention concept has to be better supported by the Austrian health system. Especially 
in societies with major changes in the type of diet consumed, reductions in physical 
activity, and increases in overweight and obesity diabetes develops strongly. 9% of 
people with overweight and more than 15% with obesity develop diabetes, whereas only 
3% of all people with normal weight suffer from diabetes. Educational advertising and 
sensitization become more important in new instructions like the “Disease Management 
Program” (DMP). An agenda called “Therapy active” for T2DM may affect positively 
the reduction of late chronic complications and with it the total cost caused by diabetes 
[ÖDG, 2010]. 
2.1.5 Economic Aspects of Diabetes  
Increasing prevalence of diabetes and high incidence of late complications lead to 
significant problems for the health care system in developed and non-developed 
countries. The management of diabetics should be further optimized in order to reduce 
the prevalence of long-term complications. Comprehensive economic data on the costs 
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of diabetes are required for policy decisions, in order to upgrade the allocation of 
resources and to evaluate the success of different attempts for disease management. The 
“CODE-2 study” described the first coordinated effort to measure the cost caused by 
people with T2DM in Europe. This study calculated total healthcare costs for more than 
7000 patients in eight countries (Belgium, France, Germany, Italy, Netherlands, Spain, 
Sweden and United Kingdom). The total costs of T2DM in these countries were 
estimated at EUR 29 billion. The average annual costs per patient were estimated at 
EUR 2.834,-.The greatest direct costs are due to CVD. Most of recruited patients in the 
study were older than 65 years and were treated with oral anti diabetic agents 
[JÖNSSON, 2002]. 
2.2 Reactive oxygen species and oxidative stress 
2.2.1 Reactive oxygen species 
Free radicals, such as reactive oxygen species (ROS), are produced in biological 
systems. A free radical is any molecule that holds in an atomic or molecular orbit one or 
more unpaired electrons, which makes them highly reactive. Free radicals can be 
formed by losing or gaining a single electron or when a covalent bond is broken 
[HALLIWELL and GUTTERIDGE, 2007]. 
ROS are highly reactive and derivatives of the oxygen metabolism. The most commonly 
known ROS in the organism are the superoxide anion (O2˙¯), hydrogen peroxide (H2O2) 
and hydroxyl radical (OH˙). The superoxide anion is called the primary radical. The 
main source for the formation of O2˙¯ is the mitochondrial respiratory chain. But also 
exogenous sources like smoking cigarettes, unhealthy diet and physical inactivity are 
responsible for the elevated production of O2˙¯ in biological systems. Superoxide 
dismutase (SOD) converts mitochondrial superoxide to H2O2 and produces OH˙ when 
not detoxified by the enzymatic defence system. If the antioxidant system is not able to 
inactivate ROS, they can damage DNA, proteins and lipids [ROBERTS and SINDHU, 
2009]. This is shown in Fig. 1. 
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GPx = glutathione peroxidase, GSH = reduced glutathione, GSSG = oxidised glutathione 
Fig. 1: Generation and detoxification of ROS 
(Roberts and Sindhu, 2009) 
2.2.2 Oxidative stress 
Oxidative stress is defined as an imbalance between pro-oxidants and antioxidants. It 
can lead to molecular damages. Fig. 2 shows that Oxidative stress results from an 
increased level of ROS and/or decreased antioxidant defence. High levels of oxidative 
stress lead to DNA damage and cell death and often the apoptotic cascade is initiated. 
Double-strand breaks are often linked to apoptosis [HALLIWELL and GUTTERIDGE, 
2007]. 
Diabetes mellitus is associated with elevated production of free radicals and reduced 
plasma antioxidant status. These events lead to increased oxidative stress [RAHIMI et 
al., 2005]. 
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Fig. 2: Imbalance between pro-oxidants and antioxidants 
(modified after Elmadfa and Leitzmann, 2004) 
2.2.3 Oxidative stress and T2DM 
2.2.3.1 Sources of oxidative stress  
Oxidative stress plays a key role in the pathogenesis of late diabetic complications and 
has been linked to insulin resistance as well as to beta cell dysfunction. Diabetics show 
increased levels of oxidative stress leading to cell damages induced by free radicals and 
lower plasma antioxidant status. Hyperglycaemia in diabetic patients is the main source 
for oxidative stress. It can induce oxidative stress via several pathways, including the 
autoxidation of glucose, generation of advanced glycation end-products (AGE) and the 
polyol pathway activation [JAY et al., 2006]. 
Free fatty acids (FFA) and leptin are other sources of elevated oxidative stress in 
diabetes. Excessive levels of FFA lead to an overproduction of nicotinamide adenine 
dinucleotide (NADH), which may contribute to an increased formation of O2˙¯ [JAY et 
al., 2006] (Fig. 3). 
2.2.3.1.1 Oxidative stress and beta cell dysfunction 
Elevated glucose and lipid concentrations induce beta cell dysfunction. Insufficiency of 
beta cells leads to excessive production of ROS. The effect of oxidative stress in beta 
cells is strengthened because they have a low level of antioxidant enzymes. As a 
consequence, oxidative damage in beta cells is enhanced and lead to increased 
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apoptosis. Dysfunction of beta cells with reduced insulin secretion is evident before the 
progression of hyperglycaemia [NEWSHOLME et al., 2009].  
2.2.3.1.2 Oxidative stress and insulin resistance 
Oxidative stress is also characterized by insulin resistance in several tissues such as 
liver, fat and muscle. There is strong evidence that oxidative stress is related to obesity 
and T2DM [WEI et al., 2008]. Data from the Framingham Offspring Study showed a 
positive association between oxidative stress and insulin resistance among 528 obese 
subjects [MEIGS et al., 2007]. 
It has been shown in animal models in vitro, that the intake of glucose in muscle cells is 
impaired in adipocytes and L6-myocytes after exposure to oxidative stress. These data 
indicate that oxidative stress is involved in the development of insulin resistance 
[MADDUX et al., 2001; RUDICH et al., 1999]. 
 
Fig. 3: Overview of the development of diabetic complications 
(Evans et al., 2002) 
2.2.3.2 Antioxidant defences against oxidative stress 
An antioxidant is any substance that prevents, removes or delay oxidative damage to 
DNA, lipids, proteins and other molecules. Antioxidants are synthesized endogenously 
or must be obtained from the diet [HALLIWELL and GUTHERIDGE, 2007]. 
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2.2.3.2.1 Enzymatic antioxidants 
Several enzymes can detoxify reactive molecules, including superoxide dismutase 
(SOD), catalase (CAT) and glutathione peroxidase (GPX). In subjects with diabetes the 
activity of these enzymes can be decreased, leading to disabled responses of defense and 
increased oxidative stress [MOKINI et al., 2010]. 
Superoxide dismutase is present as CuZnSOD in the cytosol and as MnSOD in the 
mitochondria. It can dismutate O2˙¯ immediately to H2O2. Together with catalase in the 
lysosomes and glutathione peroxidase in the mitochondria H2O2 is detoxified to H2O 
and O2 [JOHANSEN et al., 2005]. The mechanism of enzymatic antioxidants is shown 
in Tab. 3. 
 
Tab. 3: Enzymatic antioxidants and their mechanism  
(modified after Lee et al.,2004) 
Superoxide dismutase  2 O2˙¯ + 2 H
+
 → H2O2 + O2 
Catalase       2 H2O2 → 2 H2O + O2 
Glutathione peroxidase  2 GSH + H2O2 → GSSG + 2 H2O 
GSH: reduced glutathione, GSSG: oxidised glutathione 
2.2.3.2.2 Non-enzymatic antioxidants 
The most common non-enzymatic antioxidants include Vitamin E (family of different 
tocopherols and tocotrienols) and C, carotenoids and polyphenols. The intake of 
appropriate amounts of vegetables and fruits rich in natural antioxidants is able to 
reduce oxidative stress [LEE et al., 2004]. 
Vitamin E is the major fat-soluble antioxidant that prevents lipid peroxidation. The most 
active form in humans is α-tocopherol. It is a scavenger of ROS such as O2˙¯ and ˙OH 
and can be regenerated by Vitamin C (ascorbic acid). Vitamin C is water soluble. It 
scavenges O2˙¯ and ˙OH and is a quencher of singlet O2. Ascorbic acid mainly 
regenerates α-tocopherol from α-tocopherol radical [LEE et al., 2004]. 
Carotenoids are fat-soluble and have the ability to scavenge ROS. The most effective 
quencher of singlet O2 is β-carotene and lycopene. Polyphenols are radical scavengers 
and can inhibit the peroxidation of lipids and some can also react with O2˙¯. Flavonoids 
such as catechin, quercetin and caffeic acid are very potent antioxidants [HALLIWELL 
and GUTHERIDGE, 2007]. 
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Antioxidants and nutrients increase the resistance of cells against oxidative stress. The 
treatment of lymphocytes ex vivo with an oxidant (mainly with H2O2) gives information 
about the antioxidant capacity [DUSINSKA and COLLINS, 2008]. 
2.3 Comet Assay 
The comet assay, also known as single cell gel electrophoresis assay (SCGE) has 
become one of the standard methods for assessing oxidative DNA-damage. It is a 
method for measuring DNA strand breaks in eukaryotic cells. Lymphocytes are often 
used in human studies, since they are easy to obtain. Furthermore they circulate through 
the whole body and therefore reflect the level of damage in the whole organism 
[COLLINS et al., 2008].  Ostling and Johanson configured the Comet assay for the 
detection of double strand breaks in mammalian cells for the first time in the year 1984 
[OSTLING and JOHANSON, 1984]. The method was further optimized by Singh et al. 
[SINGH et al., 1988] and Olive et al. [OLIVE et al., 1991]. Under alkaline conditions 
the SCGE assay allows the detection of single-strand breaks, double strand breaks, 
oxidised bases and one can measure the cells’ sensitivity against external damage, as 
well as DNA repair. Lesion specific enzymes are able to convert oxidized pyrimidines 
and purines into additional DNA strand breaks. Endonuclease III (Endo III) recognizes 
oxidized pyrimidines while oxidized purines are recognized by Formamidopyrimidine 
glycosylase (FPG). Several dietary intervention trials, clinical and biomonitoring studies 
report on the use of SCGE assay for the detection of DNA damage [COLLINS, 2004; 
KASSIE et al., 2000; MØLLER et al., 2000]. 
2.3.1 Oxidative DNA damage in DM measured by comet assay  
In a review by MØller and Loft, it is shown that the levels of DNA damage are elevated 
in patients with diabetes [MØLLER and LOFT, 2002]. Dusinska and Collins reported 
higher levels of oxidised bases in the DNA of lymphocytes from diabetic patients 
[DUSINSKA and COLLINS, 2008]. Particularly glycaemic control in diabetics is 
important for the significance of DNA events. It was seen that subjects with poor 
glycaemic control have elevated levels of DNA damage in comparison to better 
controlled diabetics and healthy subjects [HANNON-FLETCHER et al., 2000]. 
According to the literature, conflicting results were reported in subjects with diabetes 
and DNA damage. 
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Collins et al. reported that DNA strand breaks and Endo III-sensitive sites in 
lymphocytes were significantly higher in T1DM (IDDM) subjects with poor glycaemic 
control when compared to controls. FPG-sensitive sites were not significantly increased 
in the diabetes group [COLLINS et al., 1998].  
On the other hand, Anderson et al. and Hannon-Fletcher et al. found no significant 
differences in the levels of DNA damage from diabetic subjects (IDDM and NIDDM) 
with good glycaemic control when compared to the healthy controls [ANDERSON et 
al., 1998; HANNON-FLETCHER et al., 2000]. 
Several studies reported, that in leukocytes increased levels of FPG-sensitive sites in 
subjects with T2DM (NIDDM) when compared with healthy individuals were seen 
[DINÇER et al.; 2002; PITOZZI et al., 2003].  
Another study including 52 patients with T2DM (NIDDM and IDDM-T2) reported also 
significant higher amounts of Endo III- and FPG-sensitive oxidative DNA damage in 
lymphocytes when compared to the healthy control group (n = 55) [BLASIAK et al., 
2004]. 
Choi et al. found a correlation between HbA1c levels in subjects with T2DM (NIDDM) 
and damages of DNA in lymphocytes. The results of this cross-sectional study (n = 427) 
showed that oxidative DNA damage is significantly increased in diabetics with poor 
glycaemic control and is associated with a lower status of plasma ascorbic acid [CHOI 
et al., 2005].  
Song et al. studied the amount of DNA damage in 92 subjects with normal glucose 
tolerance (NGT), 78 subjects with impaired glucose regulation (IGR), 113 patients with 
T2DM (NIDDM), which were newly diagnosed. The newly diagnosed individuals 
showed significant higher FPG-sensitive sites compared to the IGR subjects. The 
subjects with diagnosed diabetes had an elevated level of HbA1c (8.01 ± 1.89). In 
patients with IGR higher levels of DNA damage was observed than in subjects with 
NGT [SONG et al., 2007]. 
Another study investigated the differences of DNA damage in leukocytes from 25 
T2DM (NIDDM) subjects undergoing haemodialysis in comparison to 20 healthy 
controls. When compared to the controls, the patients with T2DM showed elevated 
levels of DNA damage [BRAMBILLA BAGATINI et al., 2008]. 
16  Literature survey 
A study with 39 T2DM (NIDDM) subjects (41 - 79 years) and 18 healthy controls aged 
between (35 - 70 years) reported on the oxidative DNA damage in leukocytes. The 
results support the former findings that oxidative DNA damage is elevated in subjects 
with diabetes and that poorly controlled subjects have significantly decreased levels in 
plasma antioxidant capacity [LODOVICI et al., 2008].  
In a more recent case-control study with 71 T2DM (NIDDM) subjects (40 - 70 years) 
and 14 healthy individuals (40 - 50 years), no significant differences in the levels of 
DNA damage were found between healthy controls and long term diabetics [IBARRA-
COSTILLA et al., 2010]. 
2.3.2 Intervention studies and Comet Assay 
2.3.2.1 The effect of antioxidants (AOs) on oxidative DNA damage  
The assumption that nutritional modulations can protect against oxidative DNA damage 
prompt the investigation whether it is possible to modify the level of DNA damage with 
antioxidative supplements and they increase the resistance of lymphocyte DNA to 
oxidation. Antioxidant (AO) intervention studies include diets with one or more food 
items as well as single or multiple AO treatment to increase the levels of AOs or 
specific types of vitamins and minerals. Several trials investigated the potential of AOs. 
2.3.2.1.1 Antioxidant Supplementation trials 
In a study by Duthie et al. 100 healthy, smoking and non-smoking males aged 50 – 59 
years were randomly assigned to the supplement or placebo group. The supplementation 
lasted for 20 weeks and contained a daily intake of 100 mg vitamin C, 280 mg α-
tocopherol and 25 mg ß-carotene. The results of endogenous DNA damage showed that 
smokers had significantly higher levels of oxidised pyrimidines than non-smokers. After 
20 weeks of supplementation a highly significant decrease in oxidative base damage 
could be shown in both smokers and non-smokers. Furthermore lymphocytes from 
subjects receiving antioxidative supplements were more resistant to H2O2 (0.1 mM or 
0.3 mM) [DUTHIE et al., 1996]. 
Another study performed by Lee et al. with 15 healthy male smokers and 5 healthy male 
non-smokers aged between 19 - 31 years investigated the effects of different 
antioxidants on DNA damage. Smokers received 200 IU of vitamin E, 500 mg of 
Vitamin C, 9 mg of β-carotene or 1.8 g of red ginseng or a placebo daily for a period of 
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4 weeks. The results showed a significant decrease in oxidative DNA damage in 
subjects supplemented with Vitamin E and red ginseng after 4 weeks in comparison to 
baseline. Smokers with Vitamin C and β-carotene supplementation had slightly reduced 
DNA damage without being significant [LEE et al., 1998]. 
Zhao et al. investigated the effect of carotenoid supplementation on 37 elderly healthy 
women (50 - 70 years) against oxidative DNA damage. The subjects received either 
mixed carotenoids with lutein, β-carotene and lycopene (4 mg each), or 12 mg of a 
single carotenoid (lutein, β-carotene or lycopene) or placebo for 56 days. Blood 
samplings were taken every 2 weeks. After 15 days of supplementation, the groups with 
mixed carotenoids and with β-carotene showed significantly lower DNA damage. At the 
end of the intervention period, all supplemented groups had significantly lower DNA 
damage [ZHAO et al., 2006]. 
The impact of carotenoids on DNA damage was also analysed by Devaraj et al. In this 
study 77 healthy subjects aged ≥ 40 years consumed for 8 weeks 6.5, 15 or 30 mg 
lycopene per day or placebo. All subjects were asked to maintain a lycopene-restricted 
diet 2 weeks before starting and during the intervention period. Subjects, receiving 30 
mg of lycopene, had significantly lower level of DNA damage after 8 weeks of 
supplementation [DEVARAJ et al., 2008]. 
2.3.2.1.2 Food intervention and Food extract trials 
A study recruited 23 healthy, non-smoking males aged 27 – 40 years. The volunteers 
were asked to consume vegetable products with lunch consecutively for a 2 week period 
each. The daily intake was 330 ml carrot-, 330 ml tomato juice and 10 g dried spinach 
powder dissolved in water or milk. The levels of DNA damage were significantly 
higher at the beginning of the experiment (before intervention) than during the 
intervention period with vegetable products. The treatment with carrot juice caused a 
significant reduction in oxidised pyrimidine bases of the DNA. The intervention with 
tomato juice or spinach did not cause any reduction in oxidised pyrimidines. Pool-Zobel 
et al. also suggest that carotenoids containing plant products can protect against 
oxidative DNA damage but the beneficial effects vary with the type of products [POOL-
ZOBEL et al., 1997]. 
The effect of a daily supplementation with extracts of vegetables and fruits to reduce the 
amount of DNA damage in peripheral lymphocytes was investigated in a study with 20 
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elderly subjects (mean age 68 years). The volunteers were treated with 850 mg fruit 
powder and 750 mg vegetable powder per day for a period of 80 days. Data 
demonstrated a significant decrease of DNA damage following supplementation. There 
was link to sex, age or smoking status [SMITH et al., 1999]. 
In a crossover designed study 10 healthy non-smoking women (23 ± 1.1 years) were 
divided into two groups. They were given either a diet of 60 g tomato puree (16.5 mg 
lycopene and 0.6 mg ß-carotene) or a tomato free diet for 21 days each. Subjects 
consumed the uncooked tomatoes with 10 g olive oil and 70 g pasta. For tomato free 
diet the subjects received pasta with olive oil. The relative tail moment was significantly 
decreased after the consumption of the tomato puree, and showed a significant increased 
resistance of the lymphocytes to oxidative stress [RISO et al., 1999].  
In another study by Porrini and Riso nine young adult women (25.4 ± 2.2 years) were 
treated with 25 g tomato puree containing 7 mg lycopene and 0.3 mg ß-carotene for 14 
days. After a run-in period (1 week) with a diet low in carotenoids they consumed 
uncooked tomato puree with pasta and 5 g of olive oil for lunch for 14 days. The levels 
of DNA damage decreased significantly in comparison to baseline after treatment with 
H2O2 (500 µmol/L). The levels of DNA damage were reduced by 50% [PORRINI and 
RISO, 2000]. 
Porrini et al. performed a dietary controlled intervention study with nine non-smoking 
females (25.2 ± 2.2 years). They consumed a diet low in carotenoids with one portion of 
spinach (150 g) per day for three weeks. After a 2 week wash-out period they were 
asked to consume spinach (150 g) and tomato puree (25 g) together for further 3 weeks, 
with 10 g olive oil. To measure H2O2 resistance the slides were treated with H2O2 (500 
µmol/L). After both supplementation periods a significant increase in resistance to H2O2 
could be shown [PORRINI et al., 2002]. 
In a parallel designed study performed by Møller et al. 43 subjects were randomized 
into three groups, receiving 600 g of fruits and vegetables, or a supplement with the 
equal amount of AOs and minerals or a placebo for a period of 24 days. Subjects were 
between 21 – 56 years old. There was no effect on oxidative DNA damage after 
consumption of fruit and vegetables or supplements. Lymphocyte resistance to H2O2 
treatment did not differ between the three groups. These unchanged effects may indicate 
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that the inherent antioxidant defines mechanisms are sufficient to protect circulating 
mononuclear blood cells from reactive oxygen species [MØLLER et al., 2003].  
In a further crossover study by Collins et al. 14 healthy non-smoking volunteers (8 
females, 6 males) (26 – 54 years) participated. The subjects were allocated randomly 
into three groups and each of which was given a different order of kiwifruit doses. A 
daily intake of 1, 2 or 3 kiwifruits lasted 3 weeks separated by a 2-week washout period. 
The amount of DNA damage was not related to the number of fruits consumed. The 
levels of DNA strand breaks in the lymphocytes after treatment with 100 µM H2O2 were 
significantly lower after the consumption of kiwifruit than in the washout-period and 
indicate an increased AO capacity. Oxidised bases (pyrimidines and purines) showed 
significantly decreased levels on oxidised DNA damage [COLLINS et al., 2003].  
Astley et al. showed in a study with 64 healthy males (18 – 50 years) that after 
carotenoid supplementation or intake of foods rich in carotenoids for 3 weeks no effects 
on oxidative DNA damage and resistance to H2O2 were seen [ASTLEY et al., 2004]. 
Gill et al. performed a parallel design dietary intervention study among 20 healthy 
individuals (mean age of 25.5 years) with a daily intake of 113 g cruciferous and 
legume sprouts for 2 weeks.  The results showed in the intervention group significantly 
higher resistance to H2O2-induced damage to DNA in comparison to the control group 
[GILL et al., 2004]. 
26 healthy individuals were recruited for a double-blind, crossover study and were 
randomly divided in two groups. Group one started with placebo intake, followed by a 
wash-out period and the treatment with a tomato drink, containing 5.7 mg of lycopene, 
3.7 mg of phytoene, 2.7 mg of phytofluene, 1 mg of ß-carotene, and 1.8 mg α-
tocopherol (mean age 25.7 ± 2.1 years). Group two started with the tomato drink 
followed by a wash-out phase and the placebo intake (mean age of 25.9 ± 3.4 years). 
Each period lasted 26 days. There were no significant changes in endogenous 
lymphocyte DNA damage following the treatment with placebo or the tomato drink. 
Riso et al. hypothesized, that there were no effects on markers of DNA damage because 
the basal levels of the healthy individuals were very low (2 – 3%) [RISO et al., 2006]. 
A recent intervention study included 8 healthy non-smoking volunteers in the average 
age of 33 ± 7 years. They consumed 300 g of Brussels sprouts daily over a period of 6 
days. The consumption led to a decrease in oxidative DNA-damage. Measurements 
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showed a significant decrease by 45% in oxidised pyrimidine bases and a reduction by 
39% in DNA damage after treatment with H2O2 [HOELZL et al., 2008]. 
In a more recent study the participants (n = 8) consumed 225 g per day homogenized 
spinach over a period of 16 days. The results showed a significant decline of H2O2-
induced damage and the reduction of oxidised pyrimidines was still significant after 
spinach consumption [MOSER et al., 2011]. 
2.3.2.2 Intervention studies with AO in diabetics and DNA damage 
AOs may have more protective effects on DNA damage among subjects with diabetes, 
who suffer from higher levels of oxidative stress [MØLLER and LOFT; 2006].  
An 8 week intervention study investigated 42 subjects with T1DM (IDDM) and 31 
healthy individuals. In the randomized prospective double-blind placebo-controlled trial 
the subjects were treated with a supplement of 400 IU α-tocopherol or placebo per day. 
In week 4 and 8, and 4 weeks after the intervention blood samplings were taken. There 
were no significant effects on DNA strand breaks and on H2O2 resistance in both groups 
[ASTLEY et al., 1999]. 
The effect of a high flavonol diet (supplemented) and a low-flavonol diet was 
investigated in 10 patients with T2DM (NIDDM). It was a crossover study with an 
intervention period of 2 weeks. The subjects received a low-flavonol diet or a low-
flavonol diet supplemented with 400 g of onion or onion, tomato ketchup and herb 
supplement and 6 cups of black tea per day. A significant resistance to damage of H2O2 
to DNA was seen in the high-flavonol diet (supplemented) in comparison to the low-
flavonol diet. The results showed no change on Endo III-sensitive sites [LEAN et al., 
1999]. 
Sampson et al. studied 40 patients with T2DM (NIDDM) and 30 matched controls in a 
randomized, double–blind and placebo-controlled trial. The subjects received a 
supplement of 400 IU α-tocopherol or placebo daily. The intervention period lasted 8 
weeks followed by a 4 week wash-out phase. Blood was collected at baseline, at week 8 
and week 12. The results showed no change in any of the groups [SAMPSON et al., 
2001]. 
In a study, 32 subjects with IDDM (T1DM), NIDDM (T2DM) and healthy controls 
were supplemented with 900 mg α-tocopherol per day for 12 weeks. In contrast, 28 
patients consumed for the same time period a placebo. Blood samples were taken before 
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and after intervention. All subjects treated with α-tocopherol showed significant lower 
levels of DNA damage after intervention. The NIDDM patients showed more damage 
of DNA than the IDDM subjects [ŞARDAŞ et al., 2001]. 
2.3.2.3 The effect of fatty acids on oxidative DNA damage 
Plant oils are important sources of polyunsaturated fatty acids (PUFAs) and AOs for the 
human organism. Especially omega-3 (α-linolenic acid) and omega-6 (linoleic acid) 
PUFAs that cannot be synthesized by the body represent essential components in the 
human diet [TURNER et al., 2010]. 
It is recommended to consume omega-3 and omega-6 fatty acids at a ratio of 1:5 
[DACH, 2000]. 
In traditional diets the proportion of omega-6 fatty acids is much higher. Saturated fatty 
acids (SFAs) lead to increased LDL-cholesterol levels, which contributes to an 
increased risk for CVD. It is suggested that PUFAs have beneficial effects on lipid 
metabolism but on the other hand they might increase susceptibility to lipid 
peroxidation in LDL [PÉREZ-JIMÉNEZ et al., 2002]. 
Omega-6 fatty acids increase blood viscosity, vasospasm and vasoconstriction and 
decrease bleeding time. In addition to the beneficial effects of omega 3 fatty acids, 
which have antiinflammatory, antithrombotic, antiarrhythmic, hypolipidaemic and 
vasodilatory properties, they show positive effects in the secondary prevention of CVD, 
hypertension and T2DM. Alpha-linolenic acid (ALA; 18:3 n - 3), the essential precursor 
of omega-3 fatty acids can be converted to long chain omega-3 PUFAs which are also 
found in marine oils. ALA can be found in green leafy vegetables, flaxseeds, rapeseeds 
and walnuts, and their oils are metabolized in the human body through elongation and 
desaturation to eicosapentaenoic acid (EPA; 20:5 n - 3) and docosahexaenoic acid 
(DHA; 22:6 n-3) [SIMOPOULOS, 2003]. 
In a cross over study 21 healthy non-smoking males (28.9 ± 1.3 years) were selected 
into two groups. The first group was treated with a diet containing 5% PUFA as food 
energy for a period of 4 weeks and after a 10 week wash-out period they consumed a 
15% PUFA diet for another 4 weeks. The second group followed an identical protocol 
except that they started with the 15% PUFA diet. In addition the volunteers were treated 
with or without α-tocopherol acetate (80 mg per day) and the intake results a level of α-
tocopherol in the range of 5 -7 mg/day. DNA damage induced by 200 µM H2O2 and 
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oxidised pyrimidines were significantly decreased after the low PUFA diet but 
significantly increased following the 15% PUFA diet when α-tocopherol levels were in 
the range of 5 – 7 mg/day. These effects could not be seen in individuals taking 80 mg 
α-tocopherol per day. This study suggested that an increased amount of PUFA in the 
diet should only be recommended when an adequate antioxidant intake is ensured 
[JENKINSON et al., 1999]. 
Due to the fact that AOs have an important role in preventing the progression of long-
term complications in diabetes, a study by Balkis Budin et al. was aimed of 
investigating the effect of ALA supplementation on plasma lipids, oxidative stress and 
vascular changes in diabetic and non-diabetic rats. Diabetes was induced after an 
overnight fast by single intravenous injection of streptozotosin (50 mg/kg body weight). 
The diabetic rats with blood glucose levels > 15.0 mmol/L represented the diabetic 
group and were divided in a supplementation group with ALA (n = 8) and non-
supplementation group (n = 8). The results showed significantly higher levels of tail 
moment in diabetic rats compared to the non-diabetic rats. There was a significant 
increase in the levels of DNA damage in non-supplemented diabetic rats. The ALA 
supplementation inhibited an increase in DNA damage in diabetic rats. The amount of 
DNA damage in the ALA supplemented group was significantly lower when compared 
to diabetic rats without ALA supplementation, but it was respectively higher when 
compared to the non-diabetic rats. Balkis Budin et al. concluded that DNA damage that 
appears in diabetic rats can be repaired by ALA treatment [BALKIS BUDIN et al., 
2009]. 
Another indicator of DNA damage is the measurement of sister chromatid exchange 
(SCE). In a double-blind, cross-over study 20 normal healthy non-smoking males aged 
19 – 31 years participated. The aim was to investigate the effect of plant-oils on DNA 
damage. The diets contained 30% energy as fat including either 80 g of corn oil (20 mg 
α-tocopherol, 100 mg γ-tocopherol) or 80 g of a mix of olive- and sunflower oil (24 mg 
α-tocopherol, 2.4 mg γ-tocopherol). The results indicate that corn oil intake rich in γ-
tocopherol in spite of the high amount in omega-6 PUFA (P/S = 4.2) gives better 
protection against DNA damage than a mix of olive and sunflower oil, rich in α-
tocopherol [ELMADFA and PARK, 1999]. 
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In a pilot study the effect of almond consumption in 30 healthy regular smokers was 
studied. The subjects were randomly divided into three groups. The subjects of group 1 
and 2 received 84 g and 168 g of almonds per day respectively for a period of 4 weeks. 
The third group did not get any almonds. Compared with the control group the results 
showed decreased levels of single strand DNA breaks in the two groups with almond 
consumption. Jia et al. concluded that increased almond consumption can prevent DNA 
damage in smokers [JIA et al., 2006].  
In a larger placebo-controlled, cross-over clinical study 60 smokers aged 21.8 ± 0.2 
years were randomly assigned into two groups. Their diet was supplemented with 84 g 
whole almond powder or 120 g pork (to control for calories) for 4 weeks with a 
washout-period of 4 weeks between treatment periods. In addition a reference group 
with 30 non-smoking males aged 21.± 0.4 years was supplemented with 120 g pork per 
day. The levels of DNA strand breaks in lymphocytes were higher in smokers than in 
non-smokers. The daily almond intake reduced DNA strand breaks by 34% in smokers 
compared with pre-treatment value. Pork intake did not have any effect on DNA 
damage. After the intervention with almonds the magnitude of DNA strand breaks in 
the smokers was not significantly different from non-smokers. Li et al. hypothesize that 
vitamin E, antioxidant phenolic acids, flavonoids and other polyphenols are responsible 
for the reduction of lymphocyte DNA strand breaks in smokers [LI et al., 2007]. 
2.3.3 Conclusion comet assay literature 
These reported intervention studies demonstrate different results on the effects of 
oxidised DNA damage in lymphocytes. One main reason for these heterogeneous 
results could be the low basal levels of DNA damage in healthy individuals. In many 
cases only a small number of volunteers participated in the studies. On the other hand 
the studies present a variety of intervention strategies, supplement- or dietary 
interventions, and therefore the period of consumption was often too short to measure 
significant effects in oxidised DNA damage or other not effective. Particularly there 
were only a few studies with intervention according to the levels of DNA damage in 
diabetics detected by comet assay.  
Therefore, we investigated in our study the impact of a dietary intervention with natural 
AOs in vegetables and plant oil on DNA damage in diabetics (IDDM-T2 and NIDDM), 
IFG and healthy subjects for 8 weeks.   
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3 Materials and methods 
3.1 Study design  
The study was a randomised intervention trial and was approved by the ethics 
committee of the city of Vienna. The participants were recruited by three doctors of the 
health centre Vienna South according to inclusion and exclusion criteria, through 
supplementary flyers distributed together with the journal “Diabetes – Info” of the 
Austrian diabetes association (ÖDV) and through a presentation at the “Diabetes Day”. 
All interested subjects were invited to a presentation to learn details on the study 
schedule, the food and plant oil intake and their rights. In total ten events took place in 
the health centre Vienna South and two presentations at the ÖDV within a period from 
January to June 2010. The subjects gave their written consent, when they wanted to 
participate in the study. 130 subjects participated in the general presentation. 21 subjects 
received information via telephone. 120 subjects out of them gave their written consent. 
Altogether 111 subjects started the study. 
The subjects were randomly assigned to control or intervention group. The control 
group received information about a healthy diet. The intervention group was requested 
to consume 300 g of vegetables and 25 g of a plant oil per day. The study design is 
shown in Tab. 4. 
 
Tab. 4: Study design 
 Intervention group Information group 
IDDM-T2 24 11 
NIDDM 30 11 
IFG 9 3 
Healthy 5 6 
IDDM-T2 = insulin dependent T2DM ; NIDDM = non-insulin dependent T2 ; IFG = 
impaired fasting glucose 
3.1.1 Time schedule  
The day before intervention started, blood was collected for the first time (T0) from the 
fasting subjects. The intervention phase lasted in total eight weeks. During this time the 
subjects were requested to maintain their normal lifestyle. All subjects, who were in the 
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intervention group, consumed 300 g vegetables and 25 g plant oil daily. More blood 
samples were collected four weeks (T1) and eight weeks (T2) after the start of the study. 
A return to usual diet period of eight weeks followed and at the end blood samples were 
taken the last time at week 16 (T3). Tab. 5 shows the intervention design.  
The body weight, body height and waist circumference were recorded at all times. In 
addition to the blood samples the subjects were requested to fill in 24-h recalls, food 
frequency questionnaires (FFQ) and quality of life questionnaires (QLQ). 
 
Tab. 5: Intervention design 
    Intervention                                       Return to usual diet 
 
 
 
 
week 0         week 4      week 8          week 16 
(T0)      (T1)       (T2)                (T3) 
At all 4 time points 
Blood samplings 
Anthropometrical measurements 
Blood pressure 
Questionnaires (24-h recall, FFQ, QLQ) 
 
3.1.2 Study group 
111 subjects were included in the study according to the defined inclusion and exclusion 
criteria. The subjects with T2DM were divided to NIDDM and IDDM-T2. All subjects 
with NIDDM were treated with oral anti-diabetic drugs. Insulin and partly anti-diabetic 
drugs were taken from IDDM-T2 subjects. 
During the study it turned out that some of the planned healthy subjects met the criteria 
for IFG. The pre-diabetes state affected 12 subjects. Therefore the study group was 
divided into 4 states of health. A total of 99 subjects completed the study. A description 
of the study collective is shown in Tab. 6. 
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Tab. 6: Description of the study collective 
 Female Male Age in years 
(mean ± SD) 
BMI in kg/m
2 
(mean ± SD) 
IDDM-T2 20 16 65,0 ± 7,68 33,8 ± 6,46 
NIDDM 22 18 65,2 ± 7,38 33,3 ± 6,15 
IFG 10 1 61,0 ± 6,86 27,7 ± 4,14 
Healthy 6 6 63,8 ± 6,26 29,5 ± 3,42 
SD = standard derivation 
3.1.3 Inclusion and exclusion criteria 
The inclusion and exclusion criteria for the participants of the study are listed in the 
Tab. 7 and Tab. 8. 
 
Tab. 7: Inclusion criteria 
Men and women with T2DM 
o 40 – 80 years of age 
o Treatment with oral antidiabetics or insulin 
For at least 4 weeks prior starting the study: 
o Constant medication concerning glucose, lipid and uric 
acid metabolism 
o Constant dietary habits and physical activity 
o Steady body weight 
HbA1c ≤ 9,5 % (fluctuation ˂ 10 %) 
Total cholesterol ˂ 300 mg/dl (with or without medication) 
Serum-triglycerides ˂ 500 mg/dl ( with or without medication) 
Creatinine ˂ 2,5 mg/dl 
Medication of the non-insulin-dependent group: Metformin, DPP-IV-Inhibitors, 
Sulfonylureas, GLP-1 Mimetics 
Medication of the insulin-dependent group: insulin or insulin and metformin 
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Tab. 8: Exclusion criteria 
Men and women with T1DM 
Patients younger than 40 and older than 80 years 
Smokers 
Pregnant and breastfeeding women 
Participation in another clinical trial 
New medication or change of medication concerning glucose, lipid and uric acid 
metabolism 4 weeks before starting the study 
Intake of fish oil capsules and other fatty acids 
During or prior starting the study intentions of changing 
o Eating habits 
o Physical activities 
o Body weight 
Cardiovascular diseases, defined by NYHA- classification ≥ III 
Liver diseases (transaminase-threshold higher than ≥ 2,5 times) 
Chronic renal failure (dialysis patients or creatinine ˃ 2,5 mg/dl) 
Organ transplantation 
Gastrointestinal malabsorption (pancreatic insufficiency, steatorrhea, short bowel 
syndrome) 
Systematic steroids 
Drug and alcohol abuse (≥ 80 g/d); methadone intake during the last 2 years 
Cancer, HIV 
Glitazone intake 
3.1.4 Vegetables and plant oil 
For the study we used a walnut-oil (intervention oil), which was rich in PUFAs and α-
tocopherols. A list of the ingredients of this plant oil is shown in Tab. 9. 
The frozen vegetables were kindly donated by “Iglo Austria”. The main focus was on 
green vegetables, which are rich sources of folic acid. Tab. 10 lists the vegetables 
available for the subjects during the intervention. 
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Tab. 9: Intervention oil 
% of total fatty acids  
C16:0 7.28 ± 0.09 
C18:0 2.06 ± 0.07 
C18:1n9c 16.40 ± 0.99 
C18:1n7c 0.95 ± 0.03 
C18:2n6c 61.76 ± 1.00 
C18:3n3 11.49 ± 0.43 
mg/100 g oil  
γ-tocopherol 32.98 ± 1.82 
α-Tocophero 2.76 ± 0.14 
 
 
Tab. 10: Vegetables  
Broccoli Courgette 
Brussels sprouts Green beans 
Cabbage turnip Maize 
Carrots Peas 
Cauliflower Soya beans 
Cos lettuce Spinach 
 
Recipe suggestions for the subjects were provided from the study team. 
3.2 Principles of method 
The comet assay is a widely used method for the detection of DNA damage and gives 
information the number of single and double strand breaks. The cells are embedded in 
agarose on a microscope slide. Then they are lysed for removing proteins, membranes, 
cytoplasm and nucleoplasmic constituents. The DNA is left as a nucleotide with a 
compact structure, but without histones. Under alkaline conditions the DNA unwinds 
and is electrophoresed later. In the electrophoretic field damaged DNA migrates faster 
as the compact and undamaged DNA and forms a comet like image. After staining, the 
comets can be evaluated with a fluorescence microscope (Fig. 4). For the measurement 
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of different forms of damage, nucleotides are incubated with lesion-specific repair 
enzymes. These enzymes convert oxidised bases to strand breaks. Endo III allow to 
detect oxidised pyrimidines and FPG recognises oxidised purines [COLLINS, 2004].  
 
Fig. 4: Scheme of the comet assay 
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3.2.1 Chemicals and working equipment 
3.2.1.1 Chemicals and Reagents 
Tab. 11 shows a list with the used chemicals and reagents for the measurements with 
Comet assay. 
 
Tab. 11: Chemicals and Reagents used in the Comet assay 
Substance Supplier Product number 
Bovine serum albumin (BSA) Sigma  A2153 
Dulbeccos`s Phosphate Buffered Saline (PBS) Sigma D8537 
Ethidiumbromid Solution 20µg/ml Sigma E1510 
Ethylenediamine tetraacetic acid (EDTA) Sigma E6758 
4-(2-Hydroxyethyl)piperazine-1-
ethanesulfonic acid (HEPES) 
Sigma H3375 
Hydrochloric acid (concentrated HCl)   
Potassium chloride (KCl) Riedel-de Haen 31248 
Potassium hydroxide (KOH) Sigma 60370 
Sodium chloride (NaCl) Sigma 71380 
Sodium hydroxide (NaOH) Riedel-de Haen 
Sigma 
06203 
Trizma Base (Tris) Fluka Analytical 93350 
Triton X, 
 t-Octylphenoxypolyethoxyethanol  
Sigma X-100 
Trypan blue Solution Invitrogen T10282 
Ultra Pure Agarose, normal melting Agarose 
(NMA) 
Invitrogen 16500 
Ultra Pure LMP Agarose, low melting Agarose 
(LMA) 
Invitrogen 16520 
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3.2.1.2 Equipment 
Tab. 12 shows the used equipment for the measurement for Comet assay. 
 
Tab. 12: Equipment used in the Comet assay 
Substance   Supplier 
Slides  
Coverslips 20x20 mm  
Coverslips 22x22 mm  
Centrifuge/Solid bowl centrifuge  
691 pH-Meter  Metrohm, swiss made 
Magnetic stirrer Heidolph MR 3001K 
Watherbath (GFL Müller und Scher)  
Power supply (Pequlab) 
Electrophoresis chamber 
Gloves (nitril) 
Microscope (Axioskop, Zeiss,Hitachi) 
Komet 5.5, image analysis system (Kineting 
Imaging) 
Microwave 
6 metal plates 
Tube 50 ml (for enzymbuffer) 
3.2.1.3 Preparation of general solutions and reagents 
All solutions were kept at 4°C or cooled down before usage. 
 
Lysis solution (pH = 10) 
    amounts per liter 
2.5 M NaCl    146.1 g 
0.1 M EDTA      37.2 g 
10 mM Tris        1.2 g 
By addition of 10 M NaOH the pH was set to 10. 1 ml Triton X-100 per 100 ml lyses 
solution was added and mixed well. 
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H2O2 Stock solution  
Into 10 ml aqua bidest 103 µl conc. H2O2 solution was added. For H2O2 treatment a 100 
µM solution was used. 
 
Neutralising buffer 
    amounts per liter 
0.4 M Tris Base   48.44 g 
The pH was set to 7.5 by addition of concentrated HCl solution. 
 
Enzyme reaction buffer for endonuclease III and FPG, Stock solution (10 x stock) 
    amounts per 2 liter 
40 mM HEPES  190.60 g 
0.1 M KCl    149.12 g 
0.5 mM EDTA      3.00 g 
0.2 mg/ml BSA      4.00 g 
With 1 M KOH the pH was set to 8.00. Aliquots were stored at -20°C. Prior to use it got 
melted and was diluted (1:10) with aqua bidest. 
 
Electrophoresis buffer (pH > 13) 
    amounts per 2 liter 
0.3 M NaOH    24.00 g  
0.001 M EDTA    0.58 g 
 
Low melting agarose (LMA) 
200 mg LMA per 20 ml PBS 
 
Normal melting agarose (NMA) 
200 mg NMA in 20 ml aqua bidest 
 
Ethidium bromide (20 μg/mL) 
10 μl stock solution (10 mg/mL) 
5 ml aqua bidest 
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3.3 Comet Assay 
Outline protocol of comet assay is based on Azqueta [AZQUETA et al., 2009]. 
3.3.1 Slide preparation 
The NMA was heated in a microwave until the agarose was dissolved and the solution 
was clear. The jar with the agarose was placed in a water bath at a temperature of 55°C. 
The slides were dipped into the agarose. Then the back side was wiped clean with a 
paper towel and the slides were dried at room temperature over the night.  
The pre-coated slides were stored at room temperature. 
3.3.2 Lymphocyte isolation  
The cell preparation tubes Heparin were inverted 8 times immediately after blood 
sampling and were centrifuged within two hours after blood sampling. 
Before centrifugation the blood sample was remixed by inverting the tubes 5 times. 
Then it was centrifugated at 3100 rpm (rounds per minute) for 25 min at 22°C. The 
tubes were inverted one time. The cell suspension was transferred in another tube and 
filled up with PBS to 15 ml. The tubes were inverted 5 times to mix the cells and 
centrifugated at 1300 rpm for 15 min at 4°C. The supernatant was aspirated and PBS 
was added to a volume of 10 ml. The tubes were inverted 5 times again and 
centrifugated at 1300 rpm for 10 min at 4°C. After centrifugation the supernatant was 
aspirated and resuspended in 1 ml PBS. For comet assay a minimum of 240 µl cell 
suspension with a concentration of 10
6
 cells/ml was needed.  
Cell number was defined with an automated cell counter (Countess, Invitrogen). 10 µl 
of cell suspension and 10 µl trypan blue were mixed and 10 µl out of the mixture were 
transferred into a chamber slide, were living cells were counted. 
3.3.3 Embedding cells in agarose 
The slides pre-coated with NMA were used and labelled with the subject-number and 
the kind of treatment: “lysis”, “H2O2”, “buffer”, “FPG” and “EndoIII”.  
The jar with the dissolved LMA was placed in the water-bath at 37°C.  
Metal plates were chilled in the cool lab before using. The microscope slides were 
placed on the cooled plates.  
30 µl of cell suspension with a concentration of 1 x 10
6
 cells/ml was mixed with 140 µl 
of LMA. Quickly two drops, each with 70 µl, were placed on one slide and immediately 
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covered with cover slips. The slides were left in the cool lab for 5 minutes. During this 
time the agarose set.   
3.3.4 Treatment with H2O2 
The cover slips were removed gently and the slides were placed in a jar filled with 100 
µM H2O2-solution for 5 minutes at 4°C. Afterwards the slides were dipped in PBS 
shortly to wash remove the H2O2. 
3.3.5 Lysis 
The lysis solution was filled into jars. Cover slips were removed and all slides were 
placed into the jars. For the slides treated with H2O2 a separate jar was used. They were 
left in the cool lab for more than 1 h at 4°C. 
3.3.6 Enzyme treatment 
Before treatment the slides “buffer”, “FPG” and “Endo III” were washed 3 times with 
enzyme buffer each time for 5 minutes at 4°C. The buffer was dabbed off with a paper 
towel. 50 µl of buffer (as control) or FPG/Endo III solution was placed on the gels and 
covered with cover slips. The slides were put into a moist box and were incubated at 
37°C for 30 minutes. The cover slips were removed after the end of the incubation 
period. 
The slides labelled with “lysis” and “H2O2” remained in the lysis solution until the end 
of the incubation period. 
3.3.7 Alkaline treatment 
The electrophoresis buffer was cooled before use. All slides were placed side by side 
with two in a row in the electrophoresis tank. Gaps in a row were filled up with a blank 
slide. The electrophoresis buffer was added until the slides were completely covered. 
Incubation period was 20 minutes. 
3.3.8 Electrophoresis 
The electrophoresis was running 30 min at 25 V and around 300 mA. When 25 V was 
not reached or the current was too high, some buffer was removed.  
3.3.9 Neutralisation 
The slides were removed from the electrophoresis and washed with neutralising buffer 
in a jar at 4°C for 5 min followed by 5 min with water. Afterwards excessive water was 
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dabbed off and the slides were left at room temperature over the night in the dark for 
drying. 
3.3.10 Staining 
30 µl ethidium bromide was placed on the gel and covered with a cover slip. The 
stained slides were kept in the dark until they were scored. 
3.3.11 Quantitation 
For the evaluation of DNA damage Komet 5.5 image analysis software, which was 
linked to a fluorescent microscope was used. For each sample two gels with each 50 
cells were randomly scored. The percentage of DNA in the tail (% tail DNA) was 
determined and the mean was calculated. 
3.3.12 Statistical analysis 
All data are expressed as mean ± standard derivation (SD). The data were analysed with 
SPSS 17.0 for Windows. The normality test was performed by the Kolmogorov-
Smirnov test. For baseline comparisons unpaired t-test and the one way ANOVA were 
used. A repeated-measures analysis of variance was used to measure the effect of the 
intervention. Statistical differences were considered to be significant at a value of p ≤ 
0.05. 
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4 Results and discussion 
4.1 Baseline Comparisons 
4.1.1 Clinical characteristics of the study population at baseline 
The clinical characteristics of the groups (control vs. intervention) at baseline are shown 
in Tab. 13. Body mass index (BMI), diabetes duration, HbA1c, triglycerides, fasting 
plasma glucose and C-peptide did not differ between both groups. Subjects of the 
control group were slightly but significantly younger than subjects of the intervention 
group. 
 
Tab. 13: Clinical characteristics of the control and the intervention group at 
baseline 
 Control Intervention 
N 31 68 
Age (years) 61.65 ± 6.66 65.76 ± 7.29* 
BMI (kg/m
2
) 32.21 ± 7.03 32.50 ± 5.71 
C-peptide 0.75 ± 0.41 0.90 ± 0.56 
Diabetes duration (years) 12.59 ± 9.21 15.13 ± 9.98 
HbA1c (%) 7.01 ± 1.05 7.23 ± 1.08 
Triglycerides (mmol/l) 1.45 ± 0.74 1.49 ± 0.72 
Fasting plasma glucose (mmol/l) 7.41 ± 2.07 8.12 ± 2.34 
Data are means ± SD; * indicates significant differences (p ≤ 0.05) 
4.1.2 Parameters of oxidative DNA damage at baseline of healthy, IFG- and 
diabetic subjects  
Tab. 14 shows levels of DNA damage, oxidised bases (purines and pyrimidines) and 
resistance to H2O2-induced DNA damage of IDDM-T2DM, NIDDM, IFG- and healthy 
participants at baseline. There were no significant differences between the groups with 
different health status. Healthy subjects showed slightly, but not significantly higher 
levels of DNA damage than participants with T2DM. Also levels of oxidised purines 
and pyrimidines were not significantly greater in T2DM subjects when compared to the 
healthy participants. 
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Between the control and the intervention group only IDDM-T2 participants showed 
significantly higher levels of DNA damage (Lysis) at baseline. There were no 
significant differences between control and intervention group in the NIDDM-, IFG- 
and healthy in any marker of oxidative DNA damage (Lysis, FPG, Endo III and H2O2).  
 
Tab. 14: Oxidative DNA damage in control and intervention group at baseline 
 Control Intervention 
Lysis   
IDDM-T2 4.48 ± 1.08 6.59 ± 2.99* 
NIDDM 4.36 ± 0.87 5.25 ± 1.47 
IFG 5.02 ± 0.65 5.77 ± 2.03 
Healthy 5.32 ± 1.01 4.11 ± 1.23 
H2O2   
IDDM-T2 20.62 ± 7.66 23.78 ± 9.88 
NIDDM 21.16 ± 6.42 23.50 ± 11.22 
IFG 23.73 ± 12.03 20.44 ± 12.05 
Healthy 20.73 ± 5.94 25.16 ± 9.85 
FPG   
IDDM-T2 4.42 ± 4.14 4.35 ± 2.22 
NIDDM 3.68 ± 2.18 3.46 ± 2.56 
IFG 3.72 ± 2.81 2.09 ± 1.24 
Healthy 3.00 ± 1.26 2.70 ± 1.11 
Endo III   
IDDM-T2 1.81 ± 1.05 1.51 ± 1.34 
NIDDM 1.11 ± 0.80 1.20 ± 1.00 
IFG 1.14 ± 0.44 1.31 ± 1.18 
Healthy 0.71 ± 0.32 2.01 ± 2.54 
Data are means ± SD; * indicates significant differences 
 
Various studies indicate significantly higher levels of oxidative DNA damage in 
diabetics, when compared to healthy subjects [COLLINS et al., 1998; LODOVICI et al., 
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2008; SONG et al., 2007]. Other studies describe significantly higher levels of FPG-
sensitive sites in T2DM subjects when compared to healthy individuals [DINÇER et al., 
2002; PITOZZI et al., 2003].  
The results of this study do not show higher levels of DNA damage in subjects with 
diabetes. Our measurements are in accordance with results from Hannon-Fletcher et al. 
[HANNON-FLETCHER et al., 2000] and Ibarra-Costilla et al. [IBARRA-COSTILLA 
et al., 2010]. They suggest that there are no significant differences in levels of DNA 
damage between healthy and diabetic subjects. A possible explanation for not finding 
any differences within our study might be that the participants with diabetes were 
metabolically stable and displayed good glycaemic control. 
4.1.3 Association between Connecting-peptide (C-peptide) and resistance to 
H2O2-induced DNA damage at baseline 
T2DM is characterised by insulin resistance and relative insulin deficiency. Insulin is 
produced by beta-cells of the pancreas. First, pro-insulin is secreted, which can be split 
in C-peptide and insulin. Insulin and C-peptide are always produced in similar amounts 
and therefore C-peptide levels can be used as a marker of insulin secretion. 
Measurements of an elevated insulin level without increased C-peptide concentration 
indicate insulin treatment [HORN et al., 2002]. The participants of the whole study 
group (including healthy and diabetic subjects) displayed a weak none-significant 
association between C-peptide and resistance to H2O2-induced DNA damage (r = -
0.187, p = 0.073) at baseline (T0). In NIDDM subjects this association was much 
stronger and significant (r = -0.329, p = 0.047). The correlation is shown in Fig.5. This 
result indicates that the more insulin is produced by the pancreas or the fewer beta-cells 
are destroyed, the smaller are the levels of DNA damage after treatment with 100 µM 
H2O2. 
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Fig. 5: Association between C-peptide and resistance to H2O2-induced DNA damage in subjects 
with NIDDM at baseline (r = -0.329, p = 0.047) 
The aim of an animal experiment in Wistar rats was to investigate the association 
between oxidative stress and decreased beta-cell function induced by elevation of 
plasma free fatty acids (oleate infusion). The study group demonstrated that the 
permanent exposure to free fatty acids leads to decreased insulin and C-peptide response 
in beta-cells. Therefore they concluded that oxidative stress has impact on beta-cell 
secretion [OPRESCU et al., 2007]. If we combine the results of Orpescu et al. with 
findings in our study one could conclude that increased oxidative stress leads to 
decreased beta-cell function, which is associated with reduced resistance of 
lymphocytes to H2O2. 
4.1.4 Impact of glycaemic control (HbA1c and fasting plasma glucose) on 
oxidative DNA damage 
In order to evaluate the influence of glycaemic control on DNA damage the whole study 
group was subdivided into good (HbA1c ≤ 7%) and poor (HbA1c > 7%) glycaemic 
controlled subjects. The measurements showed no significant differences in oxidised 
DNA damage and also not in resistance to H2O2-induced DNA damage at baseline. 
Dinçer et al. evaluated in T2DM subjects with poor glycaemic control significantly 
higher levels of FPG-sensitive oxidative DNA damage. In comparison to good 
controlled subjects 63 T2DM subjects and 41 healthy controls participated in this study. 
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Subjects were subdivided into well controlled and poor controlled (> 6.2%) diabetics 
according to their HbA1c levels [DINÇER et al., 2002]. Lodovici et al. demonstrated in 
39 T2DM subjects that poor glycaemic controlled T2DM subjects had a slightly lower 
plasma antioxidant status and greater levels of DNA damage when compared to healthy 
controls (n = 18). In their study the subjects with good glycaemic control were defined 
as HbA1c ≤ 7% and with serum glucose concentration ≤ 139 mg/dl (7.7 mmol/l) 
[LODOVICI et al., 2008].  
When our total study group was subdivided into the group according to their fasting 
plasma glucose, the subjects with fasting plasma glucose levels > 6.2 mmol/l showed 
significantly higher levels of oxidised purines than the subgroup of subjects with normal 
fasting plasma glucose (≤ 6.2 mmol/). These effects are shown in Fig.6. 
 
Fig. 6: Oxidised purines in subjects with normal and elevated levels of fasting plasma glucose at 
baseline (p ≤ 0.05). 
Our findings support the hypothesis that hyperglycaemia results in increased oxidative 
stress leading to elevated oxidative DNA damage.  
NIDDM subjects with high fasting plasma glucose levels did not show significantly 
higher levels of FPG-sensitive DNA lesions (3.99 ± 2.62) compared to subjects with 
low fasting plasma glucose (2.41 ± 1.52). 
Collins et al. demonstrated in T1DM subjects, that the amount of FPG-sensitive DNA 
damage is significantly increased in subjects with higher glucose levels in comparison 
to subjects with normal levels [COLLINS et al., 1998]. Similarly, Lodovici et al. found 
Baseline Comparisons 41 
 
an association between higher FPG-sensitive DNA damage and higher concentration of 
plasma glucose in subjects with T2DM [LODOVICI et al., 2008]. Choi et al. found that 
DNA-damage is significantly correlated with fasting plasma glucose and HbA1c. 
Furthermore they reported that oxidative DNA damage was significantly higher in 
T2DM subjects with poor glycaemic control and low levels of plasma ascorbic acid (< 
47.7 µM) than in subjects with a similar degree of hyperglycaemia but higher 
concentrations of plasma ascorbic acid (≥ 47.7 µM) [CHOI et al., 2005].  
4.1.5 Impact of age, BMI, diabetes duration and triglyceride concentrations 
At baseline, there were no associations between oxidative DNA damage and age, BMI, 
diabetes duration and triglyceride concentrations in the whole study population.  
When subjects were divided into groups regarding to their state of health, there was also 
no impact of age, BMI, diabetes duration and triglyceride concentrations on oxidative 
DNA damage. 
Piperakis et al. also demonstrated that oxidative DNA damage is affected by age. Lower 
resistance to H2O2-induced DNA damage was observed in the older healthy subjects 
(aged between 55 - 60 years) when compared to younger healthy subjects (aged 20 - 25 
years) [PIPERAKIS et al., 1998]. Bagatini et al. found no association between DNA 
damage and age in subjects with T2DM at baseline [BAGATINI et al., 2008]. 
To the best of our knowledge there are no data so far published about an association 
between BMI or diabetes duration and oxidative DNA damage in T2DM. 
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4.2 Effect of the intervention 
The following chapters which report the effects in the whole study group, the control 
and the intervention group, were written together with Simone Pleifer and are identical 
with the thesis “Influence of a Dietary Intervention on oxidative DNA-damage in 
Insulin-dependent Diabetes mellitus Type 2”. 
Furthermore the following chapters describe the effect of the intervention on subjects 
with NIDDM in comparison to NIDDM controls. The measured parameters HbA1c, 
fasting plasma glucose, triglycerides and age showed an influence on oxidative DNA 
damage in these participants. An aim of this study was also to verify the association of 
the intake of mixed vegetables and plant oil which led to increased plasma vitamin 
concentrations and levels of lymphocyte DNA damage. Furthermore, results of dietary 
and supplementation intervention studies are discussed and compared with findings of 
our study. 
4.2.1 Effect of the intervention in control and intervention group 
The results showed no significant changes in levels of DNA strand breaks, resistance to 
H2O2, oxidised purines and pyrimidines in the control group during the whole study 
period.  
In the intervention group the levels of DNA damage changed significantly during the 
intervention period. The decrease in DNA damage was 17.63% after 4 weeks in 
comparison to baseline, but these results were not significant. The high SD at baseline 
in the intervention group was mainly responsible for the insignificant changes. After 8 
weeks of intervention, a significant decrease by 20.77% in DNA damage was seen when 
compared to baseline. This is shown in Fig. 7.  
The intervention group also displayed positive effects in the resistance to H2O2-induced 
DNA damage, but the differences were not significant (T0: 23.32 ± 10.59, T1: 23.11 ± 
7.88, T2: 21.76 ± 7.45, T3: 22.86 ± 7.99). No effects were seen in the levels of FPG- 
and Endo III-sensitive oxidative DNA damage. 
The results showed slightly higher levels of oxidative DNA damage at T3 (after return 
to normal diet) in comparison to T2 (after 8 weeks of intervention). DNA damage was 
not significantly higher at baseline when compared to T3. 
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Fig. 7: Levels of DNA damage were significantly decreased in the intervention group but remained 
constant in the control group (p ≤ 0.05; * indicates a significant difference from baseline; T0 = 
baseline, T1 = after 4 weeks, T2 = after 8 weeks). 
A number of studies have evaluated the effects of antioxidants in vegetables or as 
supplements on DNA damage. Depending on the experimental design, the intervention 
showed beneficial or no effects on the levels of DNA damage or resistance to DNA 
damage when treated with H2O2.  
Our findings are in agreement with those of Pool-Zobel et al. Their study showed a 
significant decrease in oxidative DNA damage after consumption of carrot juice for 2 
weeks [POOL-ZOBEL et al., 1997]. 
However, Riso et al. and Porrini et al. reported a significant increase in the resistance to 
H2O2-induced DNA damage (treated with 500 µmol/l H2O2-solution) [RISO et al., 
1999; PORRINI et al., 2002]. On the contrary, no effects of a daily intervention in 
healthy subjects with 600 g of fruits and vegetables for 24 days on oxidative DNA 
damage, resistance to H2O2-induced DNA damage (treated with 150µmol/l), FPG- and 
Endo III-sensitive DNA damage were seen [MØLLER et al., 2003]. A dietary 
intervention with carotenoid-rich foods or supplementation with carotenoids for 3 
weeks had no effect on oxidative DNA damage and resistance to H2O2-induced DNA 
damage (treated with 100 µmol/l H2O2) [ASTLEY et al., 2004]. A study performed by 
Gill et al. showed after a dietary intervention with cruciferous and leguminous sprouts 
for 2 weeks significantly increased resistance to H2O2-induced DNA damage (75 µmol/l 
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H2O2-solution). But the intervention had no effect on DNA damage and oxidised 
purines [GILL et al., 2004]. After consumption of 300 g Brussels sprouts per day for 6 
days levels of oxidative DNA damage were decreased. The results showed significantly 
reduced levels of oxidised pyrimidines and higher resistance to H2O2-induced DNA 
damage [HOELZL et al., 2008].  
A long term supplementation with multivitamin tablets containing Vitamin E, C and β-
carotene showed no effects on DNA strand breaks. But after 20 weeks increased 
resistance to H2O2-induced DNA damage and lower levels of Endo III-sensitive sites 
were observed [DUTHIE et al., 1996]. After intake of 60 mg or 6 g Vitamin C per day 
for 2 weeks in a cross-over study (6 weeks between the treatment periods) no effects on 
DNA damage and H2O2 resistance were observed [ANDERSON et al., 1997]. 
In conclusion, our results show that the daily consumption of 300 g vegetables and 25 g 
of plant oil significantly reduce oxidative DNA damage in T2DM subjects. In our study 
we demonstrated that an intervention of 4 weeks with different vegetables and plant oil 
showed a reduction, which was due to the high SD at baseline not significant. After 8 
weeks of intervention the reduced DNA damage was significant. So far conflicting 
results on vegetable and supplementation trials have been reported. One explanation for 
that could be that our intervention was over a longer time period (8 weeks of 
intervention) than the other trials. Another reason is the study group itself. Most of the 
studies so far were performed with healthy subjects. We investigated effects on 
diabetics, which are less studied in this respect so far. After treatment with H2O2, the 
resistance to DNA damage was improved, but statistically not significant. The reason 
could be that the concentration of 100 µmol/l H2O2-solution was not high enough for 
greater impact on lymphocyte DNA damage. Other studies have used a concentration up 
to 500 µmol/l.  
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4.2.2 Effect of the intervention on NIDDM 
NIDDM subjects in the intervention-group showed slightly, but not significantly higher 
levels of oxidative DNA damage than the volunteers in the control-group at baseline 
(Tab.12).  
During the intervention-period the volunteers showed significant effects after 4 weeks 
(a reduction by 16.57%, T1). The changes were also significant after 8 weeks (T2) of 
intervention with a reduction by 18.29% in respect to baseline (T0). These effects are 
shown in Fig. 8 (control group: T0: 4.36 ± 0.87, T1: 4.36 ± 0.77, T2: 4.80 ± 1.36 and 
T3: 4.74 ± 1.25; intervention group: T0: 5.25 ± 1.47, T1: 4.38 ± 1.07, T2: 4.29 ± 1.03 
and T3: 4.54 ± 0.97). 
The intervention and control group of NIDDM subjects represented no significant 
changes after 16 weeks when the subjects returned to usual diet (T3) in comparison to 
T0.  
 
 
Fig. 8: The NIDDM subjects showed significantly decreased levels of oxidised DNA damage after 4 
and 8 weeks of the intervention period, while levels remained constant in control group (p ˂ 0,05; * 
indicates significant differences from baseline; T0 = baseline, T1 = after 4 weeks, T2 = after 8 
weeks). 
The NIDDM subjects showed no significant changes in H2O2-induced oxidative DNA 
damage during the 8 weeks of intervention and after return to usual diet (T0: 23.50 ± 11. 
22, T1: 22.30 ± 8.08, T2: 21.24 ± 8.45 and T3: 21.35 ± 7.08). The high SD was mainly 
responsible for the insignificant changes. 
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The level of oxidised purines decreased insignificantly by 34.43% after 4 weeks of 
intervention (T1), but during the following 4 weeks the levels of FPG-sensitive sites 
increased (T0: 3.34 ± 2.57, T1: 2.19 ± 1.44, T2: 3.18 ± 2.12 and T3: 3.48 ± 1.78). The 
intervention in NIDDM subjects also showed effects on oxidised pyrimidines. There 
was a reduction by 38.28% detected after 4 weeks of intervention (T1), but the level of 
ENDO III-sensitive sites increased after 8 weeks of intervention (T2) the level of 
ENDO III-sensitive sites increased (T0: 1.28 ± 1.03, T1: 0.79 ± 0.72, T2: 1.53 ± 1.40 
and T3: 2.12 ± 1.67). We also measured significantly higher levels of ENDO III-
sensitive sites after 8 weeks in the control group of NIDDM subjects (T0: 0.79 ± 0.56, 
T1: 1.72 ± 1.64, T2: 2.20 ± 0.22 and T3: 2.49 ± 1.59). The whole study period lasted 10 
months and blood was collected in different seasons of the year. It may be that the 
variety of seasonal changes influenced the amount of oxidised DNA damage in the 
subgroup of NIDDM subjects. Smolková et al. studied nutritional parameters and 
markers of oxidative stress in three Slovak population groups to look for an association 
of seasonal variation in diet. The consumption of vegetables was in summer and autumn 
twice as high as in winter and spring. They also observed that the DNA damage did not 
vary consistently across the seasons [SMOLKOVÁ et al., 2004]. 
Astley et al. and Sampson et al. did not see any effect of an 8 week supplementation 
with α–tocopherol (400 IU) on DNA damage and H2O2 resistance in subjects with 
T1DM or T2DM[ASTLEY et al., 1999, SAMPSON et al., 2001]. On the other hand, a 
daily supplementation with high amounts of α–tocopherol (900 IU) for 12 weeks 
showed significantly decreased levels of DNA damage in patients with T2DM and 
T1DM [ŞARDAŞ et al., 2001]. These results indicate that only high dose supplements 
of α-tocopherol over a long time period could have beneficial effects on oxidative DNA 
damage in diabetics. 
After 2 weeks of a flavonol-rich diet (supplementation with 76-110 mg of flavonols) 
among subjects with T2DM, significantly greater resistance to H2O2-induced DNA 
damage (100 µmol/l H2O2-solution) was seen, but there were no effects on levels of 
Endo III-sensitive oxidative DNA damage [LEAN et al., 1999]. These results indicate 
that also a short intervention with flavonol supplements has protective effects on DNA 
damage in subjects with T2DM. 
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In summary we could demonstrate that an intervention with natural AOs from 
vegetables and plant oil reduces the amount of DNA damage in subjects with T2DM. In 
comparison to the mentioned supplementation studies the results of our study indicate 
that dietary intake of a variety of different vegetables and plant oil have more beneficial 
influence on DNA damage than supplementation trials. Therefore it is possible to 
decrease DNA damage and probably also late diabetic complications by improving the 
diet. 
4.2.3 The impact of HbA1c on DNA damage in the intervention group 
Poorly controlled subjects (HbA1c > 7%) had slightly, but not significant higher basal 
levels of DNA damage in comparison to the better controlled subjects (HbA1c ≤ 7%) of 
the intervention group. Even after 4 weeks of consumption the oxidised DNA damage 
decreased significantly by 23.79% in the subjects with HbA1c levels > 7%. Levels 
decreased by 25.5% after 8 weeks of intervention. In contrast the better controlled 
subjects showed only a small decrease (- 10.4%) after 4 weeks. They showed significant 
reduced levels of DNA damage (- 15.18%) after 8 weeks. The levels of oxidative DNA 
damage in subjects with poor and better glycaemic control were not different any longer 
after 8 weeks of intervention. These effects are shown in Fig. 9.  
Fig. 9: Subjects with good glycaemic control (HbA1c ≤ 7%) and poor glycaemic control (HbA1c > 
7%) showed significantly decreased levels of oxidised DNA damage during and after the 
intervention-period of 8 weeks (p ≤ 0.05; * indicates a significant difference from baseline; T0 = 
baseline, T1 = after 4 weeks, T2 = after 8 weeks). 
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The effects of the intervention on resistance to H2O2-induced DNA damage are shown 
in Fig. 10. We detected a reduction by 14.24% in oxidative DNA damage after 
treatment with H2O2 in subjects with -poor glycaemic control (T0: 25.07 ± 10.86, T1: 
23.03 ± 6.88 and T2: 21.51 ± 6.43). The better controlled volunteers showed no changes 
in resistance to H2O2-induced DNA damage (T0: 21.57 ± 10.21, T1: 23.19 ± 8.87 and 
T2: 22.02 ± 8.44).  
 
Fig. 10: Subjects with poor glycaemic control (HbA1c ≤ 7%) showed a significant decrease in H2O2-
induced DNA damage after 8 weeks after of the intervention (p ≤ 0.05; * indicates a significant 
difference from baseline; T0 = baseline, T1 = after 4 weeks, T2 = after 8 weeks). 
 
Further statistical analysis confirm with the association between HbA1c and the amount 
of oxidative DNA damage (Lysis, oxidised purines and resistance to H2O2 –induced 
DNA damage). The results display significant association between the changes in 
HbA1c (T2 – T0 = ∆) and the change in oxidative DNA damage during the intervention. 
This indicates that an improvement in glucose metabolism leads to decreased levels of 
DNA damage. These effects are shown in Fig. 11, Fig. 12 and Fig. 13. There was no 
correlation seen between  oxidised pyrimidines  HbA1c in the intervention group. 
None of the associations could be observed in the control group. 
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Fig. 11: Association between HbA1c and  Lysis in the intervention group (r = 0.285, p = 0.018). 
 
 
Fig. 12: Association between  HbA1c and  resistance to H2O2-induced DNA damage in the 
intervention group (r = 0.313, p = 0.009). 
50  Results and discussion 
 
Fig. 13: Association between  HbA1c and  oxidised purines in the intervention group (r = 0.388, 
p = 0.002). 
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4.2.4 The impact of HbA1c on DNA damage in NIDDM subjects  
NIDDM volunteers with poor glycaemic control showed significantly decreased levels 
(- 27%) of oxidative DNA damage after an intervention period of 4 weeks (T0: 5.41 ± 
1.74, T1: 3.95 ± 0.69, T2: 4.27 ± 1.2). After further 4 weeks of intervention, levels rose 
a bit but were still 21.1% lower in comparison to T0. There were no significant changes 
in subjects with HbA1c ≤ 7%. This effect is shown in Fig. 14.  
Fig. 14: Subjects with poor glycaemic control (HbA1c > 7%) showed significantly decreased levels 
of oxidative DNA damage after 4 weeks of intervention (p ≤ 0.05; * indicates a significant difference 
from baseline; T0 = baseline, T1 = after 4 weeks, T2 = after 8 weeks). 
 
H2O2 resistance of lymphocytes and levels of oxidised purines and pyrimidines showed 
no significant changes in NIDDM subjects during the intervention in both groups. There 
were no significant changes detected after return to usual diet. 
4.2.5 The link between fasting plasma glucose and DNA damage 
Over the time of the intervention period, subjects with lower concentrations of fasting 
plasma glucose (≤ 6.2 mmol/l) tended to a reduction in oxidative DNA damage after 8 
weeks of intervention with - 18.18% in comparison to baseline (p ≤ 0.15; T0: 5.50 ± 
1.86, T1: 4.69 ± 1.42, T2: 4.50 ± 1.52; n = 22). Participants of the intervention group 
with greater levels of fasting plasma glucose (> 6.2 mmol/l) showed no significantly 
changes in DNA damage (p ≤ 0.05; T0: 5.87 ± 2.47, T1: 4.73 ± 1.24, T2: 4.55 ± 1.12; n 
= 46). 
The intervention showed no effect on the resistance to H2O2-induced DNA damage and 
the amount of oxidised purines and pyrimidines. 
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There were no significant changes after the return to normal diet in the amounts of DNA 
damage at week 16 in comparison to baseline and any measurement during the 
intervention period in subjects with lower (T3: 4.73 ±1.55) and higher (T3: 4.69 ± 1.10) 
fasting plasma glucose concentrations. The main reason for the insignificantly changes 
in oxidative DNA damage were the low number of subjects in this subgroup. 
4.2.6 The link between fasting plasma glucose and DNA damage in NIDDM 
subjects 
Levels of oxidative DNA damage changed significantly in NIDDM subjects with high 
levels of fasting plasma glucose (> 6.2 mmol/l). The oxidative DNA damage decreased 
significantly by 19.78% after 4 weeks (T1) and by 21.81% after 8 weeks (T2) of 
intervention when compared to baseline (T0). The levels of oxidative DNA damage 
retained constant in subjects with fasting plasma glucose ≤ 6.2 mmol/l. These effects are 
shown in Fig. 15. 
Fig. 15: NIDDM subjects with fasting plasma glucose > 6.2 mmol/l showed significantly decreased 
levels of oxidised DNA damage after 4 and 8 weeks of intervention (p ≤ 0.05; * indicates a 
significant difference from baseline; T0 = baseline, T1 = after 4 weeks, T2 = after 8 weeks). 
 
Glycaemic control is assessed by HbA1c and fasting plasma glucose. Hyperglycaemia 
is responsible for increased oxidative stress, which is leading to higher levels of 
oxidative DNA damage. In summary we showed that subjects with HbA1c > 7% or 
fasting plasma glucose > 6.2 mmol/l have higher levels of oxidative DNA damage at 
baseline. Furthermore they show a much stronger response to the intervention. These 
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changes could be due to the change in dietary habits in combination with improved 
fasting plasma and HbA1c levels. 
4.2.7 The association between triglycerides and DNA damage  
Subjects of the intervention group with triglyceride concentrations lower or higher than 
1.2 mmol/l showed a reduction (not significant) in oxidative DNA damage when 
compared to baseline. The group with lower amounts of triglycerides (≤ 1.2 mmol/l) 
displayed a higher decrease in DNA damage after 8 weeks (-24.75%) of intervention 
when compared to baseline.  
A reduction of DNA damage was also seen in the group with higher triglyceride levels 
(> 1.2 mmol/l) after 4 weeks (-12.52%) and 8 weeks (-19.24%) in comparison to 
baseline. But these results were not significant due to the high SD in both groups at 
baseline. These effects are shown in Fig. 16. 
Fig. 16: Subjects with high and low levels of triglycerides showed a reduction in DNA damage (T0 = 
baseline, T1 = after 4 weeks, T2 = after 8 weeks). 
 
The intervention showed no significant changes in resistance to H2O2-induced DNA 
damage, oxidised purines and oxidised pyrimidines at any time point of measure. 
No significant effects of DNA damage were observed between T3 (after return to 
normal diet) and T0, T1 or T2. 
Our results showed high reductions in the levels of oxidative DNA damage during the 
intervention period when considering the triglyceride levels. Decreased levels of 
oxidative DNA damage were seen in both groups. However subjects with lower levels 
of triglycerides showed a higher reduction in DNA damage than subjects with higher 
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triglyceride concentrations. Although the decrease was high, the results were not 
significant. At baseline the SD was very high in both groups, but it could be decreased 
during the intervention and the groups became more homogenous. 
To the best of our knowledge there are no data about the impact of triglycerides on 
DNA damage available. 
4.2.8 The association between triglycerides on NIDDM subjects in control 
and intervention group 
Oxidative DNA damage showed a reduction with a decrease by 19.61% in NIDDM 
subjects with higher triglycerides (> 1.2 mmol/l) after the intervention period of 8 
weeks. These results were not significant (T0: 5.15 ± 1.44, T1: 4.34 ± 1.09, T2: 4.14 ± 
1.13 and T3: 4.41 ± 1.04). This is shown in Fig. 17. 
NIDDM subjects with low triglycerides (≤ 1.2 mmol/l) showed no significant changes 
during the intervention period and after return to usual diet (T0: 4.93 ± 1.04, T1: 4.43 ± 
0.94, T2: 4.93 ± 1.07 and T3: 4.71 ± 1.07). 
 
Fig. 
Fig. 17: NIDDM subjects with high levels of triglycerides (> 1.2 mmol/l) showed no significant 
effects on oxidised DNA damage in both groups (T0 = baseline, T1 = after 4 weeks, T2 = after 8 
weeks). 
 
4.2.9 The association of age and DNA damage 
Elderly subjects (aged ≥ 60 years) of the intervention group showed significantly lower 
levels of oxidative DNA damage after 8 weeks (- 19.96%) when compared to baseline 
(T0: 5.61 ± 2.08, T1: 4.66 ± 1.34, T2: 4.49 ± 1.29 and T3: 4.71 ± 1.29). 
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In younger subjects (aged < 60 years) decreased levels of DNA damage were seen also 
after 4 weeks (- 20.12%) and after 8 weeks (- 23.67%), but these results were not 
significant (T0: 6.21 ± 3.09, T1: 4.96 ± 0.87, T2: 4.74 ± 0.93 and T3: 4.63 ± 0.92). The 
main reason for the insignificant change in this group was the high SD at baseline. This 
is shown in Tab. 18. 
Fig. 18: Subjects aged ≥ 60 years showed significantly lower levels of DNA damage after the 
intervention in comparison to baseline (p ≤ 0.05; * indicates significant differences from baseline; 
T0 = baseline, T1 = after 4 weeks, T2 = after 8 weeks). 
 
In this study, younger subjects (< 60 years) showed a significant decrease in the number 
of Endo III-sensitive sides 4 weeks when compared to baseline (T0: 2.19 ± 2.14, T1: 
1.26 ± 0.86). No significant changes were seen in the resistance to H2O2-induced DNA 
damage and oxidised purines during the intervention period. 
After the return to usual diet period at week 16, no significant effects on DNA damage 
in comparison to baseline and each intervention time point were seen in both age 
groups. 
Zhao et al. reported similar findings in a study with older healthy woman (aged between 
50 – 70 years). After supplementation with single carotenoids or mixed carotenoids for 
56 days, the levels of endogenous DNA damage were decreased [ZHAO et al., 2006]. A 
long term supplementation with extracts of vegetables and fruits for 80 days in elderly 
subjects (mean age 68 years) showed a significant decrease in the amount of DNA 
damage [SMITH et al., 1999]. Giovannelli et al. found no association between oxidative 
DNA damage and age [GIOVANNELLI et al., 2002]. 
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In conclusion the total study group showed positive effects on DNA damage during the 
intervention. In the group with the elderly subjects the reduction was significant with a 
decrease by 20%. Although the younger subjects showed a higher reduction in the 
levels of oxidative DNA damage with nearly 24%, these results were not significant. 
Responsible for that was the high SD at the beginning of the study (T0). The studies 
mentioned above showed also significantly reduced levels of DNA damage but after 
supplementation. A diet rich in vegetables and plant oil has the same beneficial effect 
on DNA damage. 
4.2.10 The association of age and DNA damage in NIDDM subjects 
In elderly (≥ 60 years) NIDDM subjects levels of oxidative DNA damage decreased 
significantly. The positive effect was detected after 4 weeks with a decrease by 18.79% 
and a reduction by 19.35% after 8 weeks of intervention in respect to baseline. In 
NIDDM subjects younger than 60 years no significant changes observed (T0: 5.27 ± 
1.49, T1: 4.28 ± 1.02 and T2: 4.25 ± 1.08). This effect is shown in Fig. 19.  
Fig. 20 shows the beneficial effect after 8 weeks of intervention in NIDDM subjects ≥ 
60 years (control group: T0: 4.45 ± 0.66, T1: 4.48 ± 0.66 and T2: 5.22 ± 1.52; 
intervention group: T0: 5.27 ± 1.49, T1: 4.28 ± 1.02 and T3: 4.25 ± 1.08).  
Two antioxidant supplementation studies are worth mentioning in this context. They 
also investigated the association between DNA damage (evaluated by the comet assay) 
and age in subjects with diabetes. An intervention trial with 400 IU α-tocopherol 
supplements for 8 weeks showed, that age was not significantly related to DNA damage 
in subjects with T2DM [SAMPSON et al., 2001]. On the other hand, Lean et al. 
reported significantly decreased oxidative DNA damage in elderly T2DM subjects (age: 
60.1 ± 7 years) after supplementation with dietary flavonols for 2 weeks [LEAN et al., 
1999].  
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Fig. 19: NIDDM subjects aged ≥ 60 years showed significantly lower levels of DNA damage after 
the intervention of 4 and 8 weeks in comparison to baseline (p ≤ 0.05; * indicates significant 
differences from baseline; T0 = baseline, T1 = after 4 weeks, T2 = after 8 weeks). 
 
 
 
 
Fig. 20: NIDDM subjects aged ≥ 60 years showed significantly lower levels of DNA damage after 4 
weeks and 8 weeks when compared to baseline (p ≤ 0.05; * indicates significant differences from 
baseline; T0 = baseline, T1 = after 4 weeks, T2 = after 8 weeks). 
 
4.2.11 The relation between oxidative DNA damage and vitamins 
Epidemiologic studies suggest that antioxidant capacity is improved by the consumption 
of vegetable products, thereby decreasing the risk of developing diseases related 
oxidative stress [PORRINI and RISO, 2000]. The intervention with  300 g vegetables 
and 25 ml plant oil led to a significant increase in α-, ß-Carotene, Lutein and γ- 
tocopherol. In the intervention group (including IDDM-, NIDDM-, healthy- and IFG-
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subjects) there were no significant correlations between changes in vitamin 
concentrations in plasma and changes in the levels of oxidative DNA-damage in 
lymphocytes. 
Astley et al. investigate the effect of mixed carotene capsules, cooked minced carrots, 
mandarin oranges and Vitamin C tablets on DNA damage and repair. The intervention 
with mixed carotene capsules and minced carrots led to a significant increase in alpha 
and beta carotene. Intervention with carrots led to a significant improvement in repair 
capacity but there were no associations between increase in repair activity and changes 
in vitamin concentrations could be observed [ASTLEY et al., 2004].  
In another study performed by Porrini et al., the effect of spinach and spinach + tomato 
puree on resistance to H2O2 induced DNA damage was investigated. The intervention 
led to increased resistance to H2O2.  After intervention with spinach +tomato an increase 
in lutein was observed. An inverse correlation between lycopene concentration in 
lymphocytes and DNA damage was observed. [PORRINI et al., 2002] Riso et al. 
investigated the effect of tomato puree on lymphocyte resistance to oxidative stress. 
They concluded that tomato products can increase resistance to H2O2 induced DNA 
damage. Since the trend in relative tail moment and plasma lycopene concentrations 
was similar, they suggest an association between lycopene concentrations and oxidative 
stress [RISO et al., 1999]. 
In an older study by Collins et al., the carotenoids lutein, zeaxanthin, lycopene, ß-
cryptoxanthin, α- and ß-carotene and vitamin E were measured in serum by HPLC. This 
study was looking for effects of carotenoid supplements on DNA damage compared 
with placebo. There were significantly increased levels in α- and ß carotene and lutein, 
and smaller increases in lycopene observed. When individual values of serum 
carotenoid concentrations were compared with the corresponding measures of 
lymphocytes DNA damage, negative correlations were seen. A negative correlation 
between endo III-sensitive sites and carotenoid concentrations was observed. 
Correlations were much stronger with lutein and ß-carotene than with lycopene. But 
there were no protective effects of carotenoid supplementation on levels of oxidative 
DNA damage [COLLINS et al., 1998]. 
Mean values of endogenous DNA damage of healthy smokers and non-smokers subjects 
aged 50-59 years were examined for any correlation with individual plasma antioxidant 
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levels by Duthie et al. A positive correlation was observed between strand breaks and α-
tocopherol in non-smokers. There were weak and non-significant correlations between 
oxidised bases and antioxidant concentrations. These authors concluded that one has to 
consider other variables that affect endogenous DNA damage, including intrinsic 
antioxidant defences, and DNA repair [DUTHIE et al., 1996]. 
Porrini and Riso observed in their study an inverse correlation between plasma lycopene 
concentration and oxidative DNA. This indicates that when dietary antioxidant intake is 
consistent, plasma antioxidant concentrations reflect well the cellular antioxidant 
capacity even if plasma is more directly subjected to the fluctuation of dietary 
antioxidant intake than cells are [PORRINI and RISO, 2000].  
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4.2.12 The relation between oxidative DNA damage and vitamins in NIDDM 
subjects 
To verify whether the level of oxidative DNA damage responded rapidly to vitamin 
intake, differences in DNA damage and vitamin concentrations between baseline (T0) 
and after 8 weeks of intervention (T2) were calculated and correlated with each other. 
NIDDM subjects showed a trend toward a correlation (r = -0.366, p = 0.051) between ∆ 
Lutein and ∆ Lysis. This effect is shown in Fig. 21. Another result, which is shown in 
Fig. 22, displays the correlation between ∆ ß-carotene and ∆ Lysis (r = -0.446, p = 
0.015). . There were no significant results observed between any of the mentioned 
parameters in the control group.  
 
Fig. 21: Association between ∆ lutein and ∆ Lysis in NIDDM subjects of the intervention group (r = 
-0.366, p = 0.051) 
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Fig. 22: Association between ∆ ß-carotene and ∆ Lysis in NIDDM subjects of the intervention group 
(r = -0.446, p = 0.015). 
 
Sampson et al. investigated the effect of 400 I.U. α-Tocopherol on DNA and LDL 
oxidative susceptibility in subjects with T2DM. They found a direct relationship 
between DNA oxidative susceptibility and plasma α-tocopherol levels at baseline, but 
the supplementation had no impact on DNA and LDL oxidative susceptibility 
[SAMPSPON et al., 2001]. 
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5 Conclusion 
The consumption of 300 g mixed vegetables and 25 ml plant oil per day led to 
significant changes in the amount of oxidative DNA damage in the whole study group. 
The protective effect of the intervention was seen in participants with diabetes type 2, 
especially in NIDDM subjects. 
In association to their stage of health, the study groups displayed no differences in the 
levels of DNA damage at baseline. Before the intervention started, recruited volunteers 
with high fasting glucose (> 6.2 mmol/l) showed significantly higher levels of oxidised 
purines when compared to participants with normal fasting glucose (≤ 6.2 mmol/l). 
They also displayed a significant correlation between C-peptide and resistance to H2O2-
induced DNA damage at baseline. 
After the intervention period the total study group showed significantly lower levels of 
DNA damage when compared to baseline. In subjects with HbA1c > 7% levels of DNA 
damage were significantly decreased after 4 and 8 weeks of intervention and subjects 
with ≤ 7 % displayed significantly lower levels of DNA damage after 8 weeks of 
intervention. H2O2-induced oxidative DNA damage was significantly reduced in 
subjects with HbA1c > 7% after 8 weeks of intervention.  
Subjects with NIDDM displayed significantly reduced DNA damage after 4 and 8 
weeks in comparison to baseline. NIDDM subjects with levels of HbA1c > 7% and 
fasting plasma glucose > 6.2 mmol/l showed significant changes of oxidative DNA 
damage after 8 weeks of intervention. Significant correlations between ∆ HbA1c and 
DNA damage indicate that better glycaemic control leads to a decreased amount of 
oxidative DNA damage in diabetics. The DNA damage in NIDDM subjects with 
triglyceride concentrations > 1.2 mmol/l was insignificantly decreased with a reduction 
of 19.61%. Levels of oxidative DNA damage were significant reduced in elderly 
subjects with NIDDM after 4 and 8 weeks of intervention. The intervention with mixed 
vegetables and plant oil rich in AOs led to a significant higher concentrations in α-, ß-
carotene, lutein and γ-tocopherol in the intervention group. In participants with NIDDM 
a correlation between change in DNA strand breaks (Lysis) and change in concentration 
of ß-carotene (p < 0.05) and lutein (p = 0.051) were observed.  
These present results are underlining the beneficial effects of a diet rich in vegetables 
and plant oil rich in PUFAs especially in people suffering from T2DM.
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6 Abstract 
At the Department of Nutritional Sciences in Vienna, a randomized controlled 
intervention study was performed to measure the impact of a nutritional intervention on 
the levels of oxidative damage in T2DM. For the DIAPLANT study three physicians 
working at Vienna Health Centre South recruited 76 T2DM subjects (41 non-insulin-
dependent (NIDDM) subjects and 35 insulin dependent T2DM subjects (IDDM-T2)), 
12 subjects with impaired fasting plasma glucose and 11 healthy subjects. The 
participants were randomly assigned to the control or intervention group. The control 
group received detailed nutritional information about the protective effects of 
antioxidants and the benefits of polyunsaturated fatty acids. The intervention group 
received 300 g mixed vegetables and 25 ml plant oil per day. The subjects were 
requested not to make any additional changes in dietary habits and lifestyle during the 
study period. Blood samples were taken to measure the amount of the DNA damage at 
baseline, after 4 weeks, after 8 weeks and after 16 weeks (after returning to normal 
eating habits). Oxidative DNA damage was measured in lymphocytes by using comet 
assay. By using this method, not only single and double strand breaks, but also oxidised 
bases (purine and pyrimidine) and resistance to H2O2-induced DNA damage was 
measured. In order to display a more accurate view, possible influencing parameters 
such as fasting blood glucose, triglycerides, age, ß-carotene and lutein which have 
increased influence on the level of DNA damage, were included in the statistical 
evaluation of results.  
The results show that the daily consumption of vegetables and high-quality plant oil rich 
in vitamins and antioxidants leads to decreased levels of oxidative DNA damage 
compared to the measurements before the start of the trial in T2DM subjects. The 
intervention showed significantly decreased levels of DNA damage in the total study 
group after 8 weeks and in NIDDM subjects also after 4 weeks in comparison to 
baseline. A slight but not significant increase in the resistance to H2O2-induced DNA 
damage was also found in the total study group. Levels of oxidised bases did not change 
significantly during the intervention. There were no significant changes in any marker 
of oxidative DNA damage in the control group. Furthermore we could show that HbA1c 
has a significant impact on DNA damage. Poor controlled volunteers with HbA1c > 7% 
had significantly lower levels of DNA damage after 4 and 8 weeks of intervention in 
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comparison to baseline. Better controlled subjects with HbA1c < 7% displayed 
significant reductions after 8 weeks of intervention. Significant correlations between 
better glucose control and oxidative DNA damage underscore the association between 
these two parameters. We also measured significant decreased levels of oxidative DNA 
damage in NIDDM subjects with fasting plasma glucose > 6.2 mmol/l after 4 weeks and 
8 weeks of intervention. DNA damage tended to decrease in NIDDM subjects with 
triglyceride concentrations > 1.2 mmol/l. In elderly subjects ≥ 60 years significant lower 
levels of oxidative DNA damage were measured after 4 weeks and they decreased even 
more after 8 weeks of consumption when compared to baseline. Participants with 
NIDDM < 60 years showed no significant changes during the intervention. The 
intervention led to significant increased concentrations in α-, ß-carotene, lutein and γ-
tocopherol in plasma. The results showed no significant associations between changes 
in vitamin concentrations and changes in the levels of DNA damage in the intervention 
group. But NIDDM subjects displayed a significant association between ∆ lutein and ∆ 
oxidative DNA damage after the intervention period. 
In conclusion, the results of our study showed that a diet rich in antioxidants and 
polyunsaturated fatty acids from natural source has positive impact on levels of 
oxidative DNA damage in subjects with T2DM. 
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7 Zusammenfassung 
Am Institut für Ernährungswissenschaften in Wien wurde eine randomisierte 
Interventionsstudie durchgeführt, um den Einfluss einer Ernährungsintervention auf das 
Ausmaß an oxidativen Schäden bei T2DM zu messen. 
Für die Studie Diaplant wurden 41 nicht-insulinpflichtige und 35 Insulinpflichtige 
T2DM Probanden (gesamt 76 T2DM), 12 Teilnehmer mit erhöhter Nüchternblutglukose 
sowie 11 Gesunde rekrutiert und zufällig zwei Gruppen zugewiesen. Die 
Kontrollgruppe erhielt Information über die positiven Eigenschaften von Antioxidantien 
und mehrfach ungesättigten Fettsäuren. Die Interventionsgruppe konsumierte täglich 
300 g gemischtes Gemüse und 25 ml Pflanzenöl und wurde angewiesen das 
Ernährungsverhalten oder den Lebensstil während der gesamten Studie nicht zusätzlich 
zu ändern. Um  das Ausmaß an DNA–Schäden zu messen, wurde zu Beginn der Studie, 
nach 4 Wochen, nach 8 Wochen sowie nach insgesamt 16 Wochen (nach Rückkehr zur 
normalen Essensgewohnheit) Blut abgenommen. Aus dem Frischblut wurden die 
Lymphozyten isoliert, und für die Detektion von DNA Strangbrüchen mittels Comet 
Assay herangezogen. Neben dem Gehalt an Einzel und Doppelstrangbrüchen wurden 
auch oxidierter Basen (Purin und Pyrimidin) und die Widerstandsfähigkeit der 
Lymphozyten gegenüber Wasserstoffperoxid gemessen. 
Um einen genaueren Einblick darstellen zu können, wurden mögliche Einflussparameter 
wie Nüchternblutglukose, Triglyzeride, Alter, ß-Carotinoide und Lutein welche 
vermehrten Einfluss auf den Gehalt von DNA-Schäden haben können, in die statistische 
Auswertung mit einbezogen. Wir konnten zeigen, dass der tägliche Konsum von 
hochwertigem Pflanzenöl und Gemüse, reich an Vitaminen und Antioxidantien bei 
T2DM zu einer Reduktion des Ausmaßes an oxidativen DNA-Schäden führt. Die 
Intervention zeigte eine signifikante Reduktion an DNA-Schäden im Gesamtkollektiv 
nach 8 Wochen und in der Gruppe der NIDDM Probanden bereits nach 4 Wochen im 
Vergleich zum Ausgangswert vor Beginn der Intervention. Eine leichte, aber nicht 
signifikante Steigerung der Resistenz gegenüber Wasserstoffperoxid konnte im 
Gesamtkollektiv gemessen werden. Der Gehalt an oxidierten Basen änderte sich 
während der Intervention nicht. Es wurden keine signifikanten Änderungen bezüglich 
der untersuchten Parameter und Veränderungen der DNA-Schäden in der 
Kontrollgruppe festgestellt. Bei schlecht eingestellten Probanden mit einem HbA1c von 
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> 7% wurde bereits nach kurzer Interventionsperiode eine signifikante Abnahme der 
DNA-Schäden erzielt im Vergleich zu Beginn der Studie. Gut eingestellte T2DM 
Probanden mit einem HbA1c von ≤ 7% zeigten erst nach längerer Interventionszeit von 
8 Wochen eine signifikante Reduktion. Signifikante Korrelationen zwischen ∆ HbA1c 
und ∆ DNA Schaden zeigten, dass eine Verbesserung der Blutzuckerwerte zu einer 
Reduktion der DNA-Schäden führen kann. Eine signifikante Abnahme von DNA-
Schäden konnte auch bei NIDDM Probanden mit erhöhter Nüchtern-Blutglukose-
Konzentration > 6.2 mmol/l bereits nach 4 Wochen und fortwehrend nach 8 Wochen 
gemessen werden. Eine leichte, aber nicht signifikante Reduktion wurde bei NIDDM 
Probanden mit erhöhter Konzentration an Triglyzeriden > 1.2 mmol/ festgestellt. Auch 
bei älteren Studienteilnehmern ≥ 60 Jahre mit NIDDM wurde eine Reduktion an 
oxidativen DNA-Schäden bereits nach 4 Wochen und noch weiter nach 8 Wochen im 
Vergleich zum Ausgangswert vor Beginn der Intervention erzielt. Studienteilnehmer < 
60 Jahren zeigten keine signifikanten Entwicklungen während der 
Ernährungsintervention. Die Intervention führte im Plasma zu einem erhöhten Anstieg 
von α-, ß-Carotinoide, Lutein und γ- Tocopherol. Während die Interventionsgruppe im 
gesamten keine signifikanten Korrelationen zwischen dem  Anstieg der 
Vitaminkonzentration im Plasma und der Reduktion von  DNA Schäden zeigte, wurde 
bei Probanden mit NIDDM eine signifikante Korrelation  zwischen ∆ Lutein und ∆ 
Lyse gemessen. Zwischen ∆ ß-Carotin und oxidativen DNA-Schaden konnte ein Trend 
eines Zusammenhangs festgestellt werden (P <0,06). 
Zusammenfassend, konnte im Rahmen dieser Studie gezeigt werden, dass eine 
Ernährungsintervention mit Gemüse und hochwertigem Pflanzenöl positiven Einfluss 
auf oxidative DNA Schäden bei T2DM hat. 
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